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Neural stem cells (NSCs) have yet to be definitively identified and isolated in 
vitro.  To facilitate the isolation of NSCs it is essential that we identify a unique set of 
cell surface markers.  Here, I performed multiplex single cell RT-PCR on mRNA from 
neurosphere derived cells with the aim of identifying novel cell surface markers for 
NSCs.  Using this methodology we identified C1qR1 (CD93) as a potential cell surface 
marker for NSCs.  C1qR1+ single cells propagated to form clonal neurospheres gave a 
5.8% NSC frequency, 6-fold higher than unsorted cells, and higher secondary 
neurosphere formation.  C1qR1 was expressed in vivo in the ventricular and 
subventricular zones of the brain, areas known to be enriched for NSCs.  C1qR1+ 
selected cells from brain had greater neurosphere formation, multipotency and self-
renewal capacity in primary cultures.  Further, C1qR1+/LeX+ cells were enriched for 
NSCs by approximately 35-fold giving a 46% NSC frequency.  C1qR1+/LeX+ cells 
expressed significantly higher levels of Hes1, Hes5, Musahsi1, nestin, Pax6, and Sox2 
than unsorted cells.  I conclude that C1qR1 is a novel marker for NSCs, and that along 
with LeX, can be used to select for a highly enriched NSC population. 
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1.1 Introduction to Stem Cells 
  
Stem cells are biological cells that can potentially develop into any of the cells 
that make up our bodies.  Functionally, stem cells are defined as cells that have the 
capacity to generate cells identical to themselves (self-renewing), as well as differentiate 
into diverse specialized progeny with more restricted potential [1,2,3].  The combination 
of these properties is often referred to as “stemness”; the minimal set of features that all 
stem cells have in common [4].  However, whether “stemness” exist is still not clear.   
 
Stem cells are present in embryonic, fetal, and adult tissues.  During development, 
stem cells are the precursors from which many cell types, and ultimately organs, are 
derived.  In the adult, stem cells contribute to tissue homeostasis and regeneration after 
injury.  Because of their regenerative potential, stem cells are being intensively studied 
for the treatment of a variety of degenerative illnesses and injuries, ranging from 
diabetes, liver and heart diseases, to neurological diseases.  
 
1.2 Pluripotent Stem Cells 
1.2.1 Embryonic Stem Cells 
 
Embryonic stem cells (ESCs) are harvested directly from the inner cell mass 
(ICM) of the pre-implantation embryos after the formation of a cystic blastocyst [5].  
Under appropriate tissue culture conditions, ESCs, unlike most differentiated cell types, 
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will proliferate indefinitely without senescence or shortening of telomeres, and retain an 
uncompromised karyotype.  ESCs are also pluripotent with the ability to give rise to cells 
derived from all three embryonic germ layers - mesoderm, endoderm, and ectoderm [6].  
These three germ layers are the embryonic source of all cells of the body (Fig. 1.1).  
When injected into the pre-implantation embryo, ESCs integrate uniformly into the 
embryo, giving rise to functional differentiated progeny in all tissues and organs [7]. 
 
Mouse ESCs were first isolated directly from delayed blastocysts and established 
in vitro by Evans and Kaufman [8], and Martin et al. [9] in 1981.  Human ESCs were 
first isolated by Bongso et al. [10] in 1994, and successfully cultured [11] in vitro by 
Thomson et al. in 1998.  Mouse ESCs are cultured in complete ES medium in the 
presence of a feeder layer of mitotically inactivated primary mouse embryonic fibroblasts 
(MEFs).  MEFs produce leukemia inhibitory factor (LIF) [12], which triggers activation 
of the latent transcription factor STAT3.  Activation of this transcription factor alone is 
necessary and sufficient to maintain mouse ESCs in an undifferentiated state [13,14,15].  
Unlike mouse ESCs, human ESCs do not respond in the same way to LIF.  In order for 
human ESCs to be maintained in an undifferentiated state, they need to be cultured on 
MEF feeder layers in the presence of basic fibroblast growth factor (bFGF) [11,16].  
Alternatively, they can be grown in MEF-conditioned growth medium, on Matrigel or 










Figure 1.1    Early embryo development. 
 
A zygote develops into a blastocyst comprising of a defined trophectodermal outer layer, 
the ICM cluster and the blastocoel cavity.  This then develops into a gastrula, where the 
three germ layers of the embryo are specified.  Ectoderm is the outermost layer and forms 
the skin, nerves and pigment cells.  Endoderm is the innermost layer and forms the 
digestive tract, the lungs and associated organs.  Sandwiched in between the two is the 





The most common method to initiate differentiation in cultured ESCs is to induce 
the formation of embryoid bodies (EBs), cell aggregates that contain derivatives of all 
three embryonic germ layers [18,19,20].  This lineage commitment of ESCs can be 
induced in a number of ways following the withdrawal of LIF and/or the feeder layer 
[21], by treating the cultures with growth factors or specific reagents such as 
dimethylsulfoxide (for muscle) [22] and retinoic acid (for neurons) [23].  Another 
approach to differentiate ESCs involves the co-culture of ESCs with stromal cell lines.  
Different stromal cell lines have been employed to promote the hematopoietic 
commitment of ESCs [24] and to produce dopaminergic neurons [25].  It has been 
reported that ESCs can be efficiently differentiated into cardiomyocytes [26], smooth 
muscle cells [27], osteoblasts [28], neurons [23], astrocytes [29], oligodendrocytes [30], 
hepatocytes [31], and many more cell types. 
 
Although reports on the establishment of human ESCs brought great expectations 
to the field of regenerative medicine, there are two big problems that need to be 
overcome before ESCs can be successfully used in medical applications.  First, the 
problem of immune rejection caused by the mismatch of human leukocyte antigen (HLA) 
haplotypes between ESCs and patients.  Second, the ethics of using human ESCs in 
medicine [32].    
 




In 2006, Takahashi and Yamanaka made a revolutionary breakthrough in the stem 
cell field.  They demonstrated that the introduction of four transcription factors (Oct3/4, 
SRY (sex determining region Y)-box 2 (Sox2), Kruppel-like factor 4 (Klf4), and myc) 
into mouse fibroblasts by retroviruses could convert them into cells closely resembling 
pluripotent ESCs [33].  These cells were named induced pluripotent stem (iPS) cells.  iPS 
cells grow as a colony on top of a monolayer of mitotically inactivated mouse embryonic 
fibroblasts.  They express pluripotency markers such as TRA-1-60, TRA-1-80, SSEA-3, 
SSEA-4, Oct4, Sox2, and Nanog.  In addition, they form teratomas when injected into the 
testes of immune-compromised mice.  When iPS cells are injected into tetraploid 
blastocysts they are capable of producing viable mice, indicating that iPS cells possess 
full developmental potential just like ESCs [34,35,36]. 
 
In 2007, Takahashi et al. and Yu et al. generated the first human iPS cells from 
adult fibroblasts.  Both groups used the same approach, but different transcription factors.  
The former group used Oct4, Sox2, Klf4, and cMyc, while the latter used Oct4 and Sox2, 
but replaced the oncogenic factors Klf4 and cMyc for Nanog and LIN28 [37,38].  Since 
then several groups have reported that human iPS cells can also be derived from other 
somatic cells such as keratinocytes [39], peripheral blood cells [40], hepatocytes [41], 
and, for the first time, cells carrying a malignant oncogenetic mutation [42].  These cell 
lines were generated by transduction using the four reprogramming factors used by 
Takahashi et al. [37].  However, it has also been reported that NSCs can be 
reprogrammed into iPSs using only one factor, Oct4, since they endogenously express 




One of the most valuable applications of iPS cells is as an in vitro model of 
human diseases.  Recently, several groups have successfully generated patient-specific 
iPS cells and then differentiated them into the cell type affected by the disease.  An 
example of such a disease is spinal muscular atrophy (SMA), a neuromuscular disorder 
caused by mutations in the SMN1 gene and resulting in the loss of lower motor neurons 
[44].  Ebert et al. generated iPS cells from a patient with SMA and differentiated them 
into motor neurons [45].  These SMA patient-specific motor neurons were shown to 
degenerate with time, demonstrating that the process of reprogramming and directed 
differentiation faithfully maintained the disease phenotype.  Apart from studying the 
dynamics of disease, these new human cell-based models can also be used as powerful 
systems for drug screening [45,46].  Furthermore, iPS cell technology provides the means 
to obtain the source of cells to be used in regenerative medicine by using a patient’s own 
pluripotent stem cells [47].   
     
Despite the value of iPS cell technology in research, and ultimately clinical 
settings, there are still several factors that impede their application for human 
therapeutics.  Firstly, similar to ESCs, these cells are highly tumorigenic in nature. 
Secondly, iPS cells are not exactly like ESCs.  Detailed examination of these cells reveal 
that they have slightly different epigenetics [40], senesce earlier than ESCs [48], and are 
less robust in differentiation [49].  Lastly, the use of viral vectors to deliver teratoma-




1.3 Multipotent Stem Cells 
1.3.1 Adult Stem Cells 
 
Adult stem cells are stem cells found in tissues or organs of an organism.  They 
are single cells that have the ability both to self-renew and to generate differentiated cells 
of a specific lineage capable of reconstituting tissues or organs.  The primary role of adult 
stem cells is to continuously maintain and repair the tissues and organs throughout the 
life span of the individual.  Unlike ESCs which originate from the ICM of the blastocyst, 
the origin of adult stem cells in mature tissues is still under investigation. 
 
Adult stem cells have been identified in many organs and tissues, including the 
brain [51], pancreas [52,53], heart [54], liver [55,56], bone marrow [57,58], peripheral 
blood [59], skeletal muscle [60,61], skin tissue[62], adipose tissue [63], teeth [64], and 
gut [65].  In addition to being able to self-renew, these adult stem cells may be uni-, bi-, 
tri- or multi-potent, with the capacity to differentiate into one, two, three or four or more 
cell types.  Each adult stem cell for a particular tissue lineage has a unique profile of cell 
surface cluster of differentiation (CD) markers.  For instance, adult cardiac stem cells 
have the surface marker profile Lin(-) c-kit(+) [54] while adult skeletal muscle stem cells 
are CD34(+) Myf-5(+) [60].  In addition, adult stem cells undergo 50-70 population 





Adult stem cells were originally thought to be committed to regenerating only 
lineage-specific cell types restricted to the tissues in which they reside.  However, several 
reports have demonstrated that adult stem cells are able to differentiate into cells that 
make up tissue different from that in which the stem cells were found [67,68,69].  Studies 
that contribute to the hypothesis of adult stem cell plasticity have shown that 
hematopoietic stem cells (HSCs), which normally generate all lineages of mature blood 
cell types, could give rise to skin [70], kidney epithelium [71], liver parenchyma [70,72], 
intestinal epithelium [70], pancreas [73], skeletal muscle [74], and neuronal cells [75,76].  
Conversely, stem cells derived from central nervous system (CNS) were able to form 
mature cells of various blood lineages when injected into lethally irradiated recipient 
mice [77].  However, studies of stem cell plasticity have been highly controversial 
[78,79,80].    
 
1.3.2 Neural Stem Cells 
 
NSCs are defined as undifferentiated cells that can both self-renew and generate 
the three major cell types that constitute the central nervous system (CNS), i.e. neurons, 
astrocytes, and oligodendrocytes [81].  NSCs are promising candidates for the 
development of cellular and genetic therapies for neurodegenerative disorders such as 
Parkinson's disease and Huntington's disease [82], and for the creation of in vitro drug 
discovery and toxicological screens [83].  Due to the lack of unique cell surface markers 
and the absence of a distinct and discernable morphological phenotype, NSCs are 
typically defined and studied based on their functional properties: 1) self-renewing - 
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giving rise to a large number of progeny, 2) multipotent – producing functional 
differentiated progeny, i.e. astrocytes, neurons, and oligodendrocytes, and 3) able to 
repair injured tissue.  However, because of technical limitations, the same cells cannot be 
tested for all three properties.  Instead, the common practice is to either show 1) and 2) in 
combination, or to perform transplantation studies and demonstrate the ability of the 
transplanted cell to survive and generate multiple relevant cell types.    
 
Recent studies have shown that some glial cells – radial glial cells in development 
[84,85,86] and specific subpopulations of astrocytes in adult mammals [87,88,89] – 
function as NSCs.  In fact, in development and in the adult brain, many neurons and glial 
cells are not the direct progeny of NSCs, but instead originated from transit amplifying or 
intermediate progenitor cells.   
 
1.3.2.1 Embryonic Neural Stem Cells 
 
 In the embryonic brain, the monolayer of neuroepithelial cells lining the ventricles 
are regarded as the first NSCs.   During the process of neurulation, neuroepithelial cells 
form the neural tube upon invagination of the neural plate (reviewed in [90]).  In early 
development, they divide symmetrically at the ventricular surface to expand the stem cell 
pool and are likely to generate early neurons.  At approximately the time when cortical 
neurogenesis begins (around E9-10 in the mouse), neuroepithelial cells elongate and 
transform into radial glial (RG) cells [84].  RG cells divide asymmetrically to generate 
neurons and oligodendrocytes either directly or indirectly through intermediate 
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progenitor cells [86,91,92].  RG cells have apical-basal polarity: apically (down), RG 
cells contact the ventricle, where they project a single primary cilium; basally (up), RG 
cells contact the meninges, basal lamina, and blood vessels [93].  At the end of 
embryonic development, most RG cells begin to detach from the apical side and 
transform into astrocytes.  A subpopulation of RG cells retain apical contact and continue 
functioning as NSCs in the neonate [94] (Fig. 1.2). 
 
 RG cells express astroglial markers such as the astrocyte-specific glutamate 
transporter (GLAST), brain lipid-binding protein (BLBP), and Tenascin C (TN-C) [95].  
They also express a variety of intermediate filament proteins including nestin, vimentin, 
the RC1 and RC2 epitopes [96], and in some species, glial fibrillary acidic protein 
(GFAP) [97,98].  These NSCs undergo distinct modes of cell division, giving rise to a 
remarkable diversity of glial and neuronal cell types in the brain and the CNS [99,100].  
With the increase in these lineage-restricted cell types, the percentage of NSCs declines 
rapidly in the brain.  While 50% of cells isolated from the spinal neural tube of E8 rats 
are stem cells, this decreases to 10% at E12 and 1% at postnatal day 1[101,102].  
 
In embryos, NSCs are found in several regions such as the cerebellum, 
hippocampus, cerebral cortex, basal forebrain and spinal cord (reviewed in [103]).  
Isolation and characterization of embryonic NSCs were described by Temple in 1989.  
Single cells isolated from E13.5-14.5 rat forebrain were plated into microwells of 














Figure 1.2    Embryonic neural stem cells in cortical development.    
 
Neuroepithelial cells in early development divide symmetrically to generate more 
neuroepithelial cells. As the developing brain epithelium thickens, neuroepithelial cells 




About 8% of these cells gave rise to clones, with only a subset of these containing 
neurons, astrocytes and cells with characteristics reminiscent of the original founder cell.  
The author suggested for the first time that these cells might be NSCs which generate 
multiple types of progeny [104].  Then in 1990, Cattaneo and McKay reported that nerve 
growth factor (NGF), combined with basic fibroblast growth factor (bFGF), enhanced the 
proliferation of these cells [105].  Similarly, Murphy et al. demonstrated that bFGF can 
directly stimulate the proliferation and survival of E10 mouse neuroepithelial cells [106].  
In 1992, Reynolds et al. demonstrated both the self-renewal and multipotentiality of E14 
mouse striatal cells by expanding them in the presence of epidermal growth factor (EGF), 
and showing that they can differentiate into neurons and glia [107]. 
 
1.3.2.2 Adult Neural Stem Cells 
 
It has become accepted that new neurons are continuously generated in the adult 
mammalian brain.  The first evidence that neurogenesis occurs in the adult brain came 
from [3H]-thymidine labeling studies conducted by Altman and Das in 1965 [108].   
However, the scientific community then did not recognize the significance of the results.  
Although Altman’s experiments were repeated and combined with electron microscopy 
in 1997 [109], and additional evidence for neurogenesis in songbirds was presented 
[110,111], the discovery of neurogenesis in the adult brain did not get much attention.  
The breakthrough came in the 1990s when new techniques for labeling dividing cells 
emerged.  New techniques, such as retroviral and bromodeoxyuridine (BrdU) labeling, 
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helped to confirm that neurogenesis occurs in discrete regions of the adult mammalian 
brain [112,113,114]. 
 
Neurogenesis occurs continuously in two regions of the adult brain, the 
subgranular zone (SGZ) of the hippocampus and subventricular zone (SVZ) of the lateral 
ventricles, and NSCs persist primarily in these two regions [115,116] (Fig. 1.3).  Adult 
NSCs can self-renew and are multipotent in culture.  In 1992, Reynold and Weiss 
reported the first in vitro isolation and characterization of NSCs from the adult brain.  
These cells isolated from adult striatal area containing the SVZ were shown to self-renew 
and give rise to neurons, astrocytes, and oligodendrocytes [117].  In 1995, Gage et al.  
isolated a population of cells with similar properties from the adult rat hippocampus 
[118].  Since then, self-renewing, multipotent NSCs have been isolated and characterized 






















Figure 1.3    Adult neural stem cells. 
 
Sagittal representation of the two neurogenic areas of the adult CNS: the olfactory bulb 
(OB) and the dentate gyrus (DG) of the hippocampus. The new neuronal cells in the OB 
are generated from NSCs of the subventricular zone (SVZ). The SVZ is a narrow zone of 
tissue in the wall of the lateral ventricle in the forebrain. The NSCs of the SVZ migrate to 
the OB via the rostro-migratory stream (RMS), where they differentiate into interneurons 















The NSCs from the adult SVZ, the SVZ astrocytes (type B cells), are derived 
from the NSCs of the embryonic and early postnatal brain [84,85,86], the radial glial 
cells[87,88,89].  Type B cells give rise to actively proliferating type C cells that function 
as transit-amplifying progenitors in the adult brain SVZ [120].  Type C cells give rise to 
young neurons or neuroblasts (type A cells), which migrate to the olfactory bulb (OB) 
through the rostral-migratory stream (RMS), where they differentiate into interneurons of 
the OB [113,121,122,123].  NSCs in the SVZ also generate both parenchymal 
oligodendrocyte progenitors and myelinating oligodendrocytes, most of which migrate 
into the neighboring corpus callosum [124,125,126].   
 
On the other hand, in the adult SGZ, there are morphologically distinct NSC 
populations: radial and non-radial (horizontal) type 1 cells [127,128].  The relationship 
between radial and horizontal NSCs remains an intriguing question as it is unclear 
whether there is a lineage connection between the two populations.  Type 1 cells are 
mostly quiescent, but transiently enter mitosis and generate the downstream neural 
lineage of committed progenitors (type 2a), mitotic neuroblasts (type 2b), postmitotic 
neuroblasts (type 3), and eventually, neurons in the dentate gyrus (DG) of the 
hippocampus [129].   Type 1 cells express both GFAP and nestin, while type 2 cells 




1.4 The Culture of Neural Stem Cells  
1.4.1 Basic Media 
 
A variety of culture conditions used for the in vitro expansion of NSCs have been 
reported.  The basic formulation is generally serum free, although some groups use serum 
for the first few days to increase cell survival and then switch to a serum-free cocktail 
[106,132,133].  The combination of Dulbecco’s modified Eagle’s medium (DMEM) with 
HAM’s F12 (DMEM/F12) supplemented with N2 or B27 is widely used for the culture of 
NSCs [107,118,134].  N2 supplement is a Bottenstein- and Sato-type hormone mix 
consisting of transferrin, insulin, putrescine, progesterone, and sodium selenate [135].  
N2 was traditionally used for NSC cultures, whereas B27 was described originally for the 
maintenance of primary neurons in culture [136].  B27 supplement contains, in addition 
to the basic formulation of N2, a range of hormones, vitamins, essential fatty acids, anti-
oxidants, and retinyl acetate [137] (Table 1.1).  As a supplement to DMEM/F12, B27 was 
found to promote the survival of freshly isolated rat embryonic NSCs.  Once the NSC 
cultures are established (i.e., passage 1), there is no advantage to using B27 over N2 
supplement for further expansion of the cells at bulk densities [134].  However, only 
B27-supplemented medium most effectively induced neurosphere formation under clonal 







               Table 1.1.  Composition of B27 and N2  
 
 B27a N2b 
BSA + + 
Transferrin + + 
Insulin + + 
Progesterone  + + 
Putrescine + + 
Sodium selenite  + + 
Biotin + - 
L-carnitine + - 
Corticosterone + - 
Ethanolamine  + - 
D(+)-galactose + - 
Glutathione (reduced) + - 
Linolenic acid  + - 
Linoleic acid  + - 
Retinyl acetate  + - 
Selenium  + - 
T3 (triodo-1-thyronine) + - 
DL-α-tocopherol (vitamine E) + - 
DL-α-tocopherol acetate + - 
Catalase + - 
Superoxide dismutase + - 
      
 a See Brewer et al. 1993 [137]. 





Besides DMEM/F12, neurobasal medium (NB) has also been used for NSC 
cultures.  NB is a modified DMEM/F12 medium, in which the osmolarity and the 
concentration of several amino acids have been reduced and ferrous sulfate eliminated.  It 
was originally described as a supportive medium for primary neuronal cultures [137,140].  
However, it has been reported that NB supplemented with B27 is superior to DMEM/F12 
supplemented with B27 for adult NSC culture, as it allows high efficacy of growth and 
expansion under clonal and low density conditions [139].  
 
1.4.2 Growth Factors 
 
 The most commonly used growth factors in NSC cultures are epidermal growth 
factor (EGF) and basic fibroblast growth factor (bFGF).  Other growth factors also appear 
to be effective for maintaining self-renewal of adult NSCs, such as Sonic hedgehog (Shh) 
[141] and amphiregulin [142].  Leukemia inhibitory factor (LIF) can also be added for 
long-term propagation of human NSCs [143].  The mitogenic effects of bFGF can be 
greatly enhanced by adding heparin to the medium [144].  EGF and bFGF are critical for 
the proliferation of NSCs isolated from the embryonic and adult forebrain germinal zone 
[51,107,117,145].  In this culture system, NSCs can proliferate in an undifferentiated 
state in vitro, which permits them to be expanded mitotically and harvested in bulk.  
Mouse E14.5 embryonic NSCs cultured at high cell plating density (50 cells/µL) were 
comparable in the presence of EGF or FGF.  However, at low cell densities (10 cells/µL), 
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greater numbers of NSCs proliferate in response to bFGF than to EGF.  A combination of 
both growth factors provides the best conditions for NSC proliferation [146,147]. 
 
Additionally, NSCs harvested from embryos of different developmental stages are 
differentially responsive to EGF and bFGF.  In serum-free conditions NSCs from E8.5 
anterior neural plate tissues proliferate in the presence of bFGF but not EGF.  However, 
these bFGF-responsive cells can generate EGF-responsive stem cells when passaged in 
vitro, suggesting that bFGF-responsive cells are the lineage precursors to the EGF-
responsive stem cells.  This was confirmed in vivo, as a separate and additive population 
of EGF-responsive stem cells can be isolated at later developmental stages.  The number 
of EGF-responsive cells increases with the induction of the EGF-receptor (EGFR).  Cells 
from early embryonic age express higher levels of FGF-receptor and lower levels of 
EGFR, whereas cells from later embryonic age express mainly EGFR [148,149]. 
  
1.4.3 Culture Systems 
 
There are essentially two culture systems for isolating and expanding the NSCs: 
the neurosphere culture system, where NSCs are cultured as free-floating sphere colonies, 
and the adherent monolayer culture system [150,151,152,153].  The neurosphere culture 
system is the method originally used to identify NSCs and has been used extensively in 
the study of NSCs due to the relative ease of use and practical handling.  With this culture 
system, the cardinal features of NSCs such as clonality, self-renewal, and 
multipotentiality can be studied conveniently and quickly [150].  However, several 
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studies have reported the drawbacks of this culture system [154,155].  One of the 
problems with the neurosphere culture system comes from the inherent properties of 
suspension culture: neurospheres are such tightly packed spheres that it is impossible to 
monitor the morphology and properties of individual cells during the culture period.  
Spatially restricted penetration of nutrients, oxygen, and effectors (e.g., growth factors, 
drugs, and reagents) may lead to variability in the response of cells within the 
neurospheres to environmental cues and thus compromise the accuracy of various studies.  
Another difficulty with the system comes from the heterogeneity of neurospheres, as each 
neurosphere contains cells at various stages of differentiation [156].  Studies using 
neurospheres should be interpreted as studies based on a mixed population of precursor 
cells, and not as studies of NSCs.  Furthermore, a recent study found that a long-term 
neurosphere culture of NSCs diminished their differentiation capacity and induced 
chromosomal instability [157]. 
 
Alternatively, NSCs can also be cultured in a defined serum-free medium with 
EGF and/or bFGF, but with the addition of a substrate such as fibronectin, laminin, or 
poly-ornithine coating on the surface of the cultureware.  Under these conditions, NSCs 
will adhere to the substrate-coated cultureware and grow as a monolayer.  This culture 
system has been increasingly used for neural developmental studies [158,159].  Cells 
grown as a monolayer culture remain separate and are continuously nurtured by the 
factors in the medium.  Moreover, the lack of tight contacts between cells minimizes the 
occurrence of spontaneous differentiation and allows direct access to individual cells for 
the testing of pharmacological agents and electrophysiological recordings.  Recently, Sun 
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et al. carried out a side-by-side comparison of proliferative capacity and passaging 
potential in both culture systems.  They found that the growth rate and self-renewal 
capacity of NSCs in adherent culture were significantly higher than those in neurosphere 
culture in the first 4 passages [160].  This advantage may be used for the large scale in 




Neurospheres are derived from a single-cell suspension of neural stem and 
progenitor cells plated in a defined serum-free medium.  The starting population of cells 
begins to proliferate after about 24 hours in culture.  By approximately day 7, depending 
on the cell source, neurospheres typically measure 100 – 200 µm in diameter and are 
composed of approximately 10,000 – 100,000 cells.  At this point the neurospheres 
should be passaged to prevent the neurospheres from growing too large, which would 
lead to necrosis as a result of the lack of oxygen and nutrient exchange at the centre of the 
neurospheres [161]. 
 
Neurospheres are free-floating spheroid structures that consist of cells producing 
their own extracellular matrix molecules, such as laminins, fibronectin, and chondroitin 
sulphate proteoglycans [162].  The spherical structure is more physiologically relevant 
than the monolayer adherent culture system and may provide the architecture required for 
adequate signaling between cells in vitro.  Mori et al. suggest that the structure of the 




Neurospheres are highly motile structures [164].  Cytoplasmic extensions 
expressed on the outer neurosphere surface are motile and constantly propel free-floating 
neurospheres through the culture medium.  As a result, neurospheres are prone to merge 
with each other and incorporate floating single cells.  In addition, neurospheres are 
heterogeneous in molecular phenotypes [156] and morphology [165].  Neurospheres with 
small sizes are negative for PAX6 and nestin, whereas large neurospheres express stem 
cell-related genes together with the restricted markers PLP/DM20 and SNAP25 [156].   
 
The developmental potential of a neurosphere changes over time.  It has been 
demonstrated that neurospheres at low passages generate more neurons and fewer 
astrocytes while long term-passage neurospheres give rise to more astrocytes and fewer 
neurons [166,167,168].  Moreover, neurospheres derived from the ventral midbrain 
initially generate dopaminergic neurons but lose this potential rapidly after a few 
passages [169,170].      
 
Cells within the neurospheres can be induced to differentiate by removing 
mitogens and plating the neurospheres on an adhesive substrate in a medium containing 
serum.  After several days, cells within the sphere will migrate centrifugally from the 
core of the neurosphere and give rise to the three major cell types that constitute CNS:  
neurons, astrocytes, and oligodendrocytes [118]. 
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Cells within neurospheres are heterogeneous in nature.  Cytofluorimetric studies 
demonstrate that cells derived from neurospheres exhibit different sizes (between 9.28 
and 19.27 µm in diameter) and cytoplasmic granularity and coexist in different phases of 
the cell cycle [165].  Besides healthy cells, neurospheres are also composed of cells in 
different phase of the apoptotic and necrotic processes [162].  In addition, only a small 
percentage of cells within each sphere holds the neurosphere-forming capacity [171] and 
even fewer fulfill the criteria of being NSCs [172].  Each neurosphere contains cells at 
various stages of differentiation, including stem cells, proliferating neural progenitor 
cells, and postmitotic neurons and glia [156,173].  Therefore, without functional 
validation, a neurosphere may be a poor model for studying the attributes of a stem cell. 
 
1.6 Clonal Analysis  
 
With the identification of multipotent stem cells in the embryonic and adult 
brains, an assay that allowed the propagation of these cells – the neurosphere assay - was 
developed and described [117].  The neurosphere assay provides a robust method for the 
isolation and expansion of NSCs.  It has also been widely used as a measure of NSC 
numbers based on the assumption that each neurosphere is derived from a single NSC, 
but this one-to-one relationship between neurosphere formation and NSC number has 
been questioned in several reports [172,174,175].  Cells and/or neurospheres were 
observed to aggregate in suspension culture [176,177], demonstrated both by time-lapse 
imaging, and by an observation that the majority of neurospheres generated from the co-
culture of EGFP- and β-galactosidase-expressing single cells were chimeric [164].  In 
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addition, it is highly unlikely that neurospheres are derived only from NSCs.  Several cell 
types other than stem cells are capable of generating neurospheres, including neural 
progenitor cells, O2A cells, oligodendrocyte precursors, and possibly even some types of 
astrocytes [51,178].  Taken together, conclusions based on the use of the neurosphere 
assay to estimate NSC numbers are poorly founded and result in an overestimation.  
 
To address this issue, clonal analysis has been strongly suggested as the only way 
to determine the true developmental potential and self-renewal capacity of a single cell in 
vitro. [179,180,181] (Fig. 1.4).  The term clonal has been used for two purposes:  the first 
is to indicate a cell grown in total isolation where the dissociated cells are deposited into 
96-well plate containing defined growth medium at a cell density of one cell per well 
[178]; the second is to specify that a group of cells (a clone) is derived from a single cell 
that was not isolated from a complex environment, i.e. a single cell that was grown on a 
feeder layer consisting of neural cells from a different animal species, which can then be 
distinguished from the test cell using antibodies [182].   
 
However, most experimenters use low cell densities ranging from 2 to 50 cells/µL 
[146,183,184,185], rather than clonal analysis, for neurosphere assays.  The assumption 
is that single cells plated at “low or clonal densities” in suspension cultures would yield 
clonal neurospheres.  However, a study using a mixture of dsRed- and YFP-labeled 
single cells showed that cell densities as low as 0.5 cells/µL still produce chimeric 
neurospheres even though the culture plates were not moved throughout the whole 
culture period [186].    
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Figure 1.4    Clonal analysis. 
 
The neural stem cell clonal analysis evaluates neurosphere-forming capacity over serial passaging followed by in vitro differentiation 
of individual spheres.  A sphere derived from a single neural stem cell upon differentiation can give rise to all three major cell types of 




The highly motile nature of single cells and neurospheres has prompted a few 
studies to look at the use of semisolid substances to promote the clonal growth of 
neurospheres.  For instance, Gritti et al. performed clonal analysis by plating the cells 
onto a methylcellulose-based semi-solid matrix [187], although the migration and fusion 
of cells/neurospheres on methylcellulose have still been reported [188].  Collagen 
substrate (NeuroCult; StemCell Technologies) [175,189,190] and agarose [186] have also 
been suggested as an easier and more accurate way to culture NSCs clonally but it 
remains to be demonstrated if these semisolid matrices can really ensure clonal growth.  
 
In conclusion, because of the dynamic nature of neurospheres, it is extremely 
difficult to maintain clonal boundaries in suspension cultures.  Currently, cells plated at 
“clonal” cell density (one cell per well) on a coated substrate and continuous observation 
with time-lapse video microscopy are the most reliable methods for clonal analysis 
[81,164,176,181,186]. 
 
1.7 Neural Stem Cell Markers 
1.7.1 Nestin 
 
Nestin is a class VI intermediate filament protein.  It is expressed predominantly 
in stem cells of the developing CNS [191].  Outside of the CNS, nestin expression has 
also been discovered in the progenitors of developing heart [192], testis [193], kidney 
[194], and skeletal muscle [195].  In the adult, nestin is expressed mainly in the 
39 
 
subependymal zone and dentate gyrus of the brain, pancreatic islets [196], renal 
podocytes [194], and at neuromuscular junctions [197].  
 
Nestin has been the most extensively used marker for identifying multipotent 
NSCs within various areas of the developing nervous system [117,198,199], but the role 
of nestin in NSC biology is still poorly understood.  Analyses using nestin-EGFP 
transgenic mice have revealed that a subpopulation of nestin positive cells is able to 
generate multipotent neurospheres [200], but nestin was shown to be present in the 
progenitor cells as well.  Upon stem cell differentiation, nestin expression is down-
regulated and replaced by other intermediate filament proteins, such as neurofilaments in 
neurons and GFAP in astrocytes [191,201].  A recent study with nestin-knockout mice 
showed that nestin is not essential for the development of the CNS but is required for the 
dispersion of acetylcholine receptor clusters during neuromuscular junction development.  




Sox2 is an SRY-related transcription factor encoding a high-mobility group 
(HMG) DNA-binding motif [203].    It plays a critical role in the maintenance of the early 
pluripotent stem cells of the epiblast [204].  It is also essential for survival of the early 




Sox2 expression is detected in the embryonic nervous system from the earliest 
stages of development, predominantly in the proliferating, undifferentiated precursors 
[206].  It is also detected in the postnatal neurogenic regions in the SVZ and 
hippocampus dentate gyrus (DG) [207,208].  Studies using the Sox2 β-geo gene as a 
transgene [209] or knock-in allele [207] showed that Sox2-expressing cells cultured from 
embryonic and adult neurogenic regions are able to self-renew and are multipotential in 
clonogenic assays, and are therefore NSCs.  Similarly, a study by Suh et al. demonstrated 
that Sox2-expressing cells in the hippocampus DG indeed behave functionally as NSCs 




Musashi-1 is a neural RNA-binding protein, which contains two RNA recognition 
motifs.  It was first discovered to be required for asymmetric cell divisions in the 
Drosophila adult sensory organ development [210].  During the embryonic stage in 
rodents, Musashi-1 is expressed predominantly in NSCs around the ventricular zone of 
neural tube, but not in fully differentiated neuronal and glial cells [211,212].  In the adult 
rodent brain, expression of Musashi-1 has been observed in SVZ astrocytes, which have 
been reported to possess NSC characteristics [213].  In addition, by using Musashi-1 as a 
marker, Pincus et al. succeeded in identifying NSCs in the adult human brain [214]. 
 
Musashi-1 has been found to function in co-operation with Musashi-2 to maintain 
the self-renewing ability of NSCs.  These two proteins act by repressing the translation of 
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m-Numb mRNA, followed by activating Notch signaling [215].  Ablation of both genes 
drastically suppressed the formation of neurospheres [216].  In addition to NSCs, 
Musashi-1 is also a marker for intestinal epithelial stem cells [217] and mammary stem 
cells [218].   
 
1.7.4 Basic helix-loop-helix genes (bHLH) Hes1 and Hes5 
 
Basic helix-loop-helix genes (bHLH) Hes1 and Hes5 are mammalian homologues 
of the Drosophila hairy and enhancer of split proteins.  Expression of Hes1 and Hes5 are 
regulated by Notch signaling [219].  In the embryonic mouse brain, they are highly 
expressed in the ventricular zone but not in other regions where differentiated cells reside 
[220,221].  It was also shown that Hes1 is expressed in the adult mouse brain [222]. 
  
Hes1 and Hes5 play an important role in the maintenance and proliferation of 
NSCs.  Overexpression of Hes1 and Hes5 in mouse embryos inhibits neurogenesis and 
maintains NSCs [223].  Conversely, in the absence of Hes1 and Hes5, NSCs are not 
properly maintained, generating fewer and smaller neurospheres [224].  Hes-related 
bHLH genes, Hesr1 and Hesr2, are also expressed by NSCs in the embryonic brain.  
Similar to Hes1 and Hes5, overexpression of Hesr1 and Hesr2 promote maintenance of 
NSC [225].  Therefore, it has been speculated that Hesr and Hes co-operatively regulate 




1.7.5 Aldehyde Dehydrogenase 
 
Aldehyde dehydrogenase (ALDH) is an intracellular enzyme responsible for 
oxidizing aldehydes to carboxylic acids [226,227].  In 1996, Jones et al. demonstrated 
that primitive murine bone marrow cells that expressed high levels of ALDH could be 
enriched using a fluorescent substrate of ALDH, termed dansyl-aminoacetaldehyde 
[228].  Subsequently, Storms et al. demonstrated that primitive human HSCs could be 
identified in umbilical cord blood (UCB) using a different and improved fluorescent 
ALDH substrate, termed BODIPY-aminoacetaldehyde (BAAA) [229].  BAAA, 
commonly known as Aldefluor, consists of a BIODIPY fluorochrome attached to an 
aminoacetaldehydee moiety which is a substrate of ALDH, and when cleaved, fluoresces 
and remains within the cell.   
 
Other than HSCs, ALDH activity has also been used as a marker for cancer stem 
cells in colon [230], liver [231], pancreatic [232], lung [233], head and neck squamous 
[234,235], and breast [236] cancers.  Recently, Corti et al. demonstrated that BAAA 
staining could be used to identify primitive NSCs that express high levels of ALDH in 
both embryonic and adult mouse brains.  Cells that are characterized by low side scatter 
(low cytoplasmic granularity) and high levels of ALDH activity (SSCloALDHbr cells) 







The LeX antigen, which is the trisaccharide 3-fucosyl-N-acetyllactosamine [238], 
also known as SSEA-1 (stage-specific embryonic antigen 1) or CD15, is highly expressed 
by pluripotent mouse blastocysts, embryonic stem cells, primordial germ cells 
[239,240,241] and rare pluripotent stem cells from adult bone marrow [242].  LeX is 
important for cell adhesion, compaction and bFGF responses of early embryonic stem 
cells; however, its function at later stages is not clear [243,244]. 
 
In 2002, Capela and Temple first demonstrated that the adult mouse SVZ NSCs 
expresses the LeX antigen, and surface LeX expression can be used to enrich NSCs by 
the process of fluorescence-activated cell sorting (FACS).   They found that these LeX-
labeled NSCs are subependymal, yet ependymal cells do not express LeX [245].  Four 
years later, they reported that LeX can also be used as a marker to purify stem cells in the 
embryonic mouse nervous system [246].  LeX expression was also reported in human 
embryonic NSCs by Klassen et al.  However, no study was carried out to verify if these 
LeX-labeled cells possess NSC characteristics [247]. 
 
In the embryonic mouse cortex, LeX is expressed on stem cells and their 
immediate progeny, the primary neuroblasts and glioblasts, but is lost in most late stage 
restricted progenitor cells and mature progeny [246].  In the adult mouse SVZ, LeX 
appears to be expressed on stem cells (type B cells) and their immediate progeny, the 
transit amplifying type C cells, but not on the subsequently generated type A neuroblasts 
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[245].  It was found that LeX expression parallels that of FGF8 and Wnt-1, suggesting 
that LeX might participate in the inductive functions of these molecules [246].  
Interestingly, Kim and Morshead showed that when side population analysis was used in 
combination with LeX expression in FACS-sorting,  further enrichment of NSCs was 
observed over the use of side population analysis alone [248].  Also, Corti et al. 
demonstrated that selection using LeX in combination with CXCR4 (CD184) sorted both 




Prominin-1 (Prom1), also known as CD133, is a glycosylated, ~120-kDa protein 
with five transmembrane domains and two large extracellular loops.  It was originally 
identified in mouse neuroepithelial stem cells and was named for its prominent location 
on the protrusions of cell membranes [250].  In humans, this protein is known to be a 
marker of primitive hematopoietic stem cells [251,252].  Phenotypical analysis of Prom1-
expressing cells in human peripheral blood identified them as primitive hematopoietic 
and myeloid progenitor cells [253], whereas Prom1-CD34+ cells were shown to consist 
mostly of B cells and more committed hematopoietic progenitors [254,255].  
Additionally, Prom1 was discovered to be a marker of cancer stem cells in human 
(reviewed in [256,257]).  It is best known for being expressed on the tumor-initiating 
population of brain neoplasms [258].  These Prom1+ cells possess a marked capacity for 
proliferation and self-renewal, and are able to form clonal neurospheres and produce new 
tumors after serial transplantation [258,259,260].  To date, Prom1 has been used to define 
45 
 
the cancer stem cell populations in lung [261], pancreatic [262], liver [231], prostate 
[263], gastric [264], and colon [265,266] cancers. 
  
In 2000, Uchida et al. successfully isolated NSCs from fresh human fetal brain 
tissues using an antibody directed towards Prom1 [198].  In their study, cells positive for 
Prom1 and negative for CD34 and CD45 were capable of forming neurospheres and 
could differentiate into both neuronal and glial cells.  Prom1 antibodies were later used 
by Lee et al. to isolate NSCs from postnatal mouse cerebellum [267].  Furthermore, Corti 
et al. reported the isolation of a Prom1-positive cell population with NSC properties from 
the embryonic (E12.5) and adult mouse forebrains [268].  However, a study by 
Pfenninger et al. indicated that Prom1 may not be present on the majority of type B 




Integrins are heterodimers of two transmembrane chains, α and β.  They are 
involved in the regulation of proliferation, survival, migration, and differentiation [270].  
Previous reports have shown that integrins β1 and α6 are expressed at high levels on 
rodent [271,272] and human [273] NSCs and can be used for their selection.  Selection 
using integrin β1 or prominin-1 was found to be equally effective at enriching human 




Integrins play an important role in NSC maintenance by activating MAPK 
signaling pathways [271].  Transient abrogation of β1 integrin binding and signaling 
using blocking antibodies results in apical process detachment from the ventricular 
surface and substantial layering defects in the postnatal neocortex, suggesting that β1 
integrin is required for anchoring embryonic NSCs to the ventricular surface and 
maintaining the physical integrity of the neocortical niche [274].  The expression of high 
levels of integrin β1 has also been successfully used to separate human epidermal stem 
cells from transit amplifying cells [275], whereas integrin α6 has been found to be a 




Notch1 is a membrane-tethered transcription factor ideally situated to integrate 
cues from the extracellular and regulate various stages of neurogenesis [280,281].  In 
response to signals presented on the surface of neighboring cells, Notch1 regulates self-
renewal and cell fate in embryonic NSCs [282,283].  Notch1 also negatively regulates 
cell cycle exit and neuronal differentiation in GFAP+ NSCs in the postnatal brain [284]. 
 
In the adult brain, Notch1 is required for maintenance of the reservoir of 
hippocampal NSCs [285].  Notch1 knock-out mice display a reduction of type 1 NSCs in 
the subgranular zone (SGZ).  NSCs from these mice have reduced cell proliferation and 
neurosphere formation in vitro.  In 1999, Notch1 was used by Johansson et al. as a 
marker to isolate NSCs from the adult mouse brain.  It was the first example of isolating 
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NSCs through immunoselection with a surface antigen [286].  Subsequently, Nagato et 
al. also demonstrated the usefulness of this marker, in combination with syndecan-1 
[272], in enriching for embryonic NSCs.    
 
1.7.10 GD3 ganglioside 
 
Gangliosides are expressed abundantly in the CNS.  The expression of 
gangliosides changes drastically during brain development [287]. For instance, in 
rodents, simple GM3 and GD3 are the predominant gangliosides in embryonic brains, but 
more complex gangliosides such as GM1, GD1a, GD1b and GT1b prevail in adult brains.  
Because of the characteristic expression patterns, some gangliosides have been used as 
developmental markers [288].  For instance, c-series gangliosides (A2B5 antigens) have 
been used as a marker of glial precursor cells [289].   
  
GD3 (NeuAcα2-8NeuAcα2-3Galβ1-4Glcβ1-1’Cer), also known as CD60a, is a b-
series disialoganglioside.  In rodent brains, GD3 is heavily concentrated in the 
subventricular zone of the lateral ventricle and the dentate gyrus of the hippocampus 
[290], where adult NSCs are localized [88,128].  Also, GD3 has been reported to be 
expressed in mouse neuroepithelial cells [291] and radial glial cells at the embryonic 
stage [292].  These observations suggest the expression of GD3 in rodent NSCs.  In 2010, 
Nakatani et al. provided direct evidence the use of GD3 as a unique cell surface marker 
to identify and isolate embryonic, postnatal and adult mouse NSCs [293].  In the human 
fetal brain, GD3 was reported to be expressed in a small population of astrocytes with a 
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high proliferation capacity [294].  Subsequently, GD3 was confirmed to be expressed in 
human NSCs by Yanagisawa et al. in 2011 [295].  
 
1.7.11 Stage-specific Embryonic Antigen 4 
 
 The stage-specific embryonic antigen 4 (SSEA4) is a glycolipid antigen with 
globo-series carbohydrate core structures [296].  SSEA4 is expressed not only by 
undifferentiated embryonic stem cells [297,298], but also by a subpopulation of dorsal 
root ganglion neurons [299] and a subpopulation of immature neural cells from the 
forebrain and spinal cord [300].  In addition, SSEA4 is expressed by non-neural cells 
such as erythrocytes [296] and multipotent progenitor cells from the fetal liver [301].  In 
2007, Barraud et al. suggested that SSEA4, in combination with Prom1, can be used for 
the enrichment of human embryonic NSCs [302].  They showed that SSEA4 is expressed 
in the proliferative areas of the developing human brain and that SSEA4+ cells are 
enriched in the Prom1+ subpopulation.  Using the neurosphere assay, they demonstrated 
that more neurospheres were generated in the Prom1+/SSEA4+ subpopulation in 






1.8 The Regulation of Neural Stem Cells 
1.8.1 Signaling Pathways 
1.8.1.1 Notch Signaling Pathway 
 
The Notch signaling pathway, originally discovered in Drosophila, is of 
fundamental importance to a wide variety of processes during embryonic development 
and in the adult [282,303].  Of particular interest, is the fact that Notch signaling 
regulates stem cells in many different settings, including the nervous system, 
hematopoietic system, skin, skeletal muscle, and gut [304].  
 
In mammals, there are four Notch receptors (Notch 1-4) and five transmembrane 
ligands (Jagged1, Jagged2, Delta-like1, Delta-like3, and Delta-like4) [305].  Under 
physiologic conditions, the Notch ligands, Delta or Jagged, expressed on neighboring 
cells, bind to the highly conserved Notch receptor and induce the proteolytic cleavage of 
Notch by γ-secretases [281,306].  The cleaved intracellular domain of Notch (NICD) 
[307] is released from the plasma membrane and translocates into the nucleus, where it 
interacts with the transcriptional regulator CBF1 (also called RBP-J or CSL) to form a 
transcriptional activator complex.  In the developing nervous system, this NICD–CBF1 
complex, which includes the co-activator Mastermind [308] among other proteins [309], 
induces the expression of Hes and Hey genes [310], which repress proneural genes and 
thereby inhibit neuronal differentiation [311] (Fig. 1.5). 








        






Figure 1.5    Notch signaling pathway. 
 
Ligand-receptor interactions lead to -secretase cleavage of Notch and release of the 
intracellular domain (NICD). This domain enters the nucleus and together with a 
complex including CBF1 and Mastermind (MAML) promotes the transcription of targets 
such as the Hes and Herp genes. These genes encode bHLH proteins that antagonize 
proneural genes such as Mash1 and the neurogenins. This antagonism blocks neuronal 
gene expression and consequently inhibits differentiation. Notch signaling may also act 
through other CBF1 targets and through CBF1-independent cascades, which involve 




Recent accumulating evidence has implicated Notch signaling in different aspects 
of NSC biology.  Using conditional gene ablation, several studies showed that the loss of 
Notch1 resulted in upregulation of proneural genes (such as Mash1 and Math1), 
precocious neuronal differentiation [312,313,314], and a reduction of NSC frequency in 
the embryonic brain [183,315].  Consistent with the Notch1 deletion phenotype, 
precocious neuronal differentiation was also observed with CBF1 deletion, as suggested 
by the decreased expression of Hes5 and increased expression of Dll1 and NeuroD [312].  
More recently, Imayoshi et al. demonstrated that the conditional deletion of CBF1 
resulted in a complete loss of NSCs in both the developing and adult telencephalon [316].  
Similarly, NSCs in Hes1 [317], Hes1 and Hes5 [219,224], and Hes1, Hes3, and Hes5 
[318] knockout mice prematurely differentiated into neurons and were depleted in most 
regions of the developing CNS.  Together, these studies indicate that Notch signaling is 
required for the maintenance and expansion of the NSC population.  Inactivation of 
Notch signaling induces neuronal differentiation and depletes NSC populations in both 
embryonic and adult brains. 
 
Importantly, this signaling pathway seems to be essential for distinguishing NSCs 
from intermediate progenitors through the expression of Notch effector CBF1, where the 
knockdown of CBF1 promotes the conversion of NSCs to progenitors.  Analyses of 
neural cells expressing GFP driven by the CBF1 promoter revealed that cells possessing 
higher activity of CBF1 generated more multipotent neurospheres and expressed higher 
level of Hes1 and Hes5, whereas cells expressing lower levels of CBF1 expressed higher 




1.8.1.2 Wnt/β-catenin Signaling Pathway 
 
The canonical Wnt signaling pathway (Wnt/β-catenin pathway) is another critical 
regulator of NSCs.  Wnt signaling is initiated when an extracellularly secreted Wnt ligand 
interacts with the seven-transmembrane-domain protein Frizzled (Fzd) and its co-
receptors Lrp5/6 [320,321].   
 
In the absence of Wnt protein, Axin and adenomatous polyposis coli (APC) in a 
multiprotein complex (the destruction complex) bind newly synthesized β-catenin.  The 
N-terminus of β-catenin is then phosphorylated by casein kinase 1 (CK1) on serine 
residue 45 and by Glycogen-synthasekinase-3β (GSK-3β) on serine/threonine residues at 
positions 41, 37, and 33 [322,323,324].  Phosphorylated β-catenin is subsequently 
targeted for ubiquitination by the β-transducing repeat-containing protein (β-TrCP) and 
eventually degraded by the proteosome [325].   
 
Upon receipt of a Wnt signal, the cytoplasmic scaffold protein Dishevelled is 
activated.  Dishevelled prevents the degradation of β-catenin through the recruitment of 
GSK-3β-binding proteins/Frat-1, which displace GSK-3β from the destruction complex 
[326].  As a consequence, stabilized β-catenin accumulates in the cytoplasm [327] and 
translocates into the nucleus, where it associates with the LEF/TCF transcription factors 
by physically displacing Groucho from LEF/TCF [328], and thus activating Wnt target 
genes, such as cyclin D1 [329,330,331] (Fig. 1.6).    
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Figure 1.6    The canonical Wnt signaling pathway. 
 
In the absence of Wnt signalling (left panel), β-catenin is in a complex with axin, APC 
and GSK3-, and gets phosphorylated and targeted for degradation.  β-catenin also exists 
in a cadherin-bound form and regulates cell–cell adhesion.  In the presence of Wnt 
signalling (right panel), β-catenin is uncoupled from the degradation complex and 
translocates to the nucleus, where its binds Lef/Tcf transcription factors, thus activating 




β-catenin represents a central and non-redundant signaling component in the 
canonical Wnt pathway.  Transgenic mice studies showed that stabilized β-catenin causes 
an overgrowth of neural progenitor cells, resulting in a grossly enlarged brain [332].  
Similarly, Adachi et al. also demonstrated that the retrovirus-mediated expression of a 
stabilized β-catenin promotes the proliferation of NSCs in the SVZ of the adult mouse 
brain [333].  On the other hand, the conditional ablation of β-catenin results in failure of 
midbrain-hindbrain development [334] and decreases the overall size of the nervous 
system and the neuronal precursor population [335].   
 
In NSC cultures, both Wnt-3a and Wnt-5a increase the proliferation of progenitor 
cells isolated from the postnatal and adult SVZ [336].  Likewise, more primary 
neurospheres are generated from Wnt-7a- and Wnt-7b-infected cells [337].  In mice 
lacking Wnt-3a, the growth of the hippocampus is inhibited due to the greatly reduced 
proliferation of precursor cells at the caudomedial margin of the developing cerebral 
cortex, the site of hippocampal development [338].  In the absence of Wnt-1, NSC 
populations in the developing midbrain and rostral hindbrain fail to expand, resulting in 
severe abnormalities in midbrain and rostral hindbrain development [339].   
 
However, the role of Wnt signaling may not be limited to NSC proliferation and 
self-renewal.  Several recent studies have provided evidence that Wnt/β-catenin signaling 
may also be involved in triggering neuronal differentiation, depending on the time and 
location of the signal [340].  Lie et al. found that Wnt-3 enhances the generation of 
neurons from adult hippocampal stem cells in vitro, and the blockade of Wnt signaling 
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abolishes neurogenesis almost completely in vivo [341].  Similarly, overexpression of 
Wnt-3a in the neocortex induces early differentiation of intermediate progenitors into 
neurons [342].  Also, for neurospheres derived from E11.5 telencephalon, treatment with 
Wnt-3a promotes differentiation into MAP2-positive neurons, reducing the population of 
self-renewing precursors [343].  It has been demonstrated that the Wnt/β-catenin 
signaling pathway promotes neuronal differentiation through its downstream target N-
myc and the neurogenic transcription factor Ngn1/2 [340,344,345]. 
 
1.8.1.3 Sonic Hedgehog Signaling 
 
Hedgehog (Hh) signaling is critical during embryonic development.  It is involved 
in the patterning of the neural tube, lung, skin, axial skeleton, and gastrointestinal tract 
[346,347,348] (reviewed in [349] and [350]).  In multiple adult tissues, Hh signaling 
remains active and contributes to differentiation, proliferation, and maintenance.  In 
contrast, deregulation of the Hh pathway is associated with birth defects and cancer 
(reviewed in [351] and [352]).  
 
In mammals, the Hh family consists of three different members, Sonic hedgehog 
(Shh), Indian hedgehog (Ihh), and Desert hedgehog (Dhh) [353,354,355,356].  Of the 
three Hh ligands, Shh is the most broadly expressed member and has been studied most 
intensively.  Hh signaling is initiated when the Shh ligand interacts with Patched1, a 
membrane-spanning receptor on the surface of Hh-responsive cells [357].  Interaction 
between Shh ligand and Ptch1 liberates a co-receptor-like molecule Smoothened from the 
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normal repressive actions of Patched1 [358,359].  Activated Smoothened accumulates in 
primary cilia [360,361].  This results in the eventual inhibition of factors that promote the 
phosphorylation/degradation of the Glioblastoma (Gli) family of transcription factors, 
and permits cellular accumulation of Gli.  Nuclear accumulation of Gli factors, in turn, 
influences transcriptional activity of Gli-target genes.  Gli1 and Gli2 generally increase 
gene transcription, while Gli3 can either increase or decrease gene transcription 
depending on its post-translational modification [362].  In the absence of Shh, Ptch1 
represses the activation of Smo, thus silencing the Smo-dependent down-stream 
intracellular signaling [363,364]. 
 
During brain development, Shh secreted from the floor plate and notochord 
regulates early ventral patterning in the neural tube [365], while later on it acts as a 
mitogen, modulating NSC proliferation in the dorsal brain, including the neocortex, 
tectum and cerebellum [366,367,368,369].  Palma and Ruiz i Altaba reported that during 
mouse development, endogenous Shh signaling regulates the number of stem cells in the 
neocortex, and hence its ultimate size.  Neocortical cells from embryonic (E18.5) Shh, 
Gli2, and Gli3 mutants generated fewer and smaller neurospheres in comparison with 
wild-type cells.  In addition, they showed that Shh signaling, in cooperation with EGF 
signaling, is required to control the proliferation of neural precursors in a concentration-
dependent manner [370].     
 
Recent findings also indicate that Shh is required for maintaining progenitor cell 
populations in the subventricular and subgranular zone of the postnatal and adult mouse 
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Figure 1.7    Sonic Hedgehog signaling.  
 
(A) Hh pathway is silent in Hh-responsive cells when Hh ligands are absent. Cells which are capable of responding to Hh ligands (i.e., 
Hh-responsive cells) express Hh receptors.  Patched (Ptc) is the receptor that physically interacts with Hh ligands.  In the absence of 
Hh ligands, Ptc represses the activation of a co-receptor-like molecule, Smoothened (Smo). This repression prevents Smo from 
interacting with other intracellular factors that permit the stabilization and accumulation of Glioblastoma (Gli) transcription factors. 
Thus, Gli proteins undergo phosphorylation by various intracellular kinases (PKA, GSK3β, CSK), become ubiquitinated, move to 
proteasomes, and are degraded.  (B) Hh ligands activate Hh pathway signaling.  Interaction between Hh ligands and Ptc liberates Smo 
from the normal repressive actions of Ptc.  This results in eventual inhibition of factors that promote Gli phosphorylation/degradation, 
and permits cellular accumulation of Gli.  Nuclear accumulation of Gli factors, in turn, influences transcriptional activity of Gli-target 
genes.  Gli1 and Gli2 generally increase gene transcription, while Gli3 can either increase or decrease gene transcription depending on 
its post-translational modification.  [adapted from Omenetti et al., 2011]  
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brain [141,371,372].  Shh promotes cell proliferation and survival in stem cell niches.  
Even quiescent adult NSCs proliferate in response to Shh signaling [373].  Conversely, 
blockage of Shh signaling by the genetic removal of Shh or pharmacological inhibition of 
Shh signaling with cyclopamine resulted in a dramatic reduction in the number of cells 
forming neurospheres and also massive cell death in the SVZ [141,371,372].  In 
summary, Shh signaling regulates NSC behavior in multiple brain niches throughout life. 
 
1.8.2 MicroRNA Regulation 
 
MicroRNAs are a newly recognized class of short (~22 nucleotides long), non-
coding RNAs that regulate gene expression post-transcriptionally in a variety of 
eukaryotes.  The first microRNA, lin-4, was discovered in Caenorhabditis elegans in 
1993 [374].  MicroRNAs exhibit distinct spatial and temporal expression throughout 
development [375,376] and each microRNA may regulate  hundreds of target mRNAs 
[377].  These regulatory small RNAs have been shown to play vital roles in diverse 
regulatory pathways [378], including apoptosis [379], hematopoiesis [380], fat 
metabolism [381], and development timing [382].  Evidence also suggests that 
microRNA expression signatures are correlated with various types of cancer [383].  
 
MicroRNAs are transcribed from the genome as long primary transcripts, called 
pri-microRNAs.  Pri-microRNAs are cleaved by Drosha, a class II RNase III enzyme, to 
produce ~70 nucleotide-long hairpin-like precursors (pre-microRNAs) [384].  These pre-
microRNAs are subsequently exported to the cytoplasm by nuclear transport receptor 
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Exportin-5 [385], where they are subject to another processing step by cytoplasmic 
RNase III Dicer to generate ~22 nucleotide-long microRNA duplexes [386,387].  These 
microRNA duplexes do not persist in the cell for long.  Usually, one strand of the duplex 
microRNA will be degraded while the other incorporates into effector complexes called 
microRNA-containing RNA-induced silencing complexes (miRISCs) [388].  miRISCs 
bind to multiple sites at the 3’ untranslated region (UTR) of target mRNAs through an 
imperfect base-pairing to modulate their expression by either of two post-transcriptional 
mechanisms: mRNA cleavage or translational repression [389] (Fig. 1.8). 
 
Studies show that ablation of Dicer causes lethality early in development, around 
embryonic day 7.5, and loss of the pluripotent stem cell population [390,391].  In 
addition, Dicer-deficient embryonic stem cells also displayed severe defects in 
differentiation both in vitro and in vivo [392].  Argonaute proteins, key components of 
RNA-induced silencing complexes, are required for stem cell maintenance [393].  These 
observations support the important role for microRNA in stem cell biology.   
 
miR-9 is one of the most interesting microRNAs, and has been extensively 
studied due to its 100% conservation among many species at the nucleotide sequence 
level.  It is expressed specifically in the neurogenic region of the rodent brain during 
neural development and in adulthood [394,395].  A study by Zhao et al. showed that 










     





Figure 1.8    A model for microRNA action in neural stem cells. 
 
microRNAs are initially transcripted in the nucleus as pri-microRNAs.  The pri-
microRNAs are processed into pre-miRNAs (hairpin) and transferred to the cytosol, 
where it is processed into 22-24 nucleotide mature miRNAs.  Upon differentiation, 
miRNAs, such as miR-124 and miR-34a, are highly expressed in the neuronal lineage, 





differentiation through the suppression of orphan nuclear receptor TLX expression.  In 
utero electroporation of miR-9 duplexes into the developing mouse brain reduced the 
abundance of TLX proteins and led to premature differentiation and outward migration of 
the transfected NSCs.  Interestingly, TLX also acts as a transcriptional repressor of miR-
9, suggesting a feedback loop between miR-9 and TLX that controls the balance between 
NSC proliferation and differentiation [396].  In contrast, a study by Delaloy et al. 
suggested that miR-9 promotes proliferation but limits the excessive migration of human 
embryonic stem cell–derived neural progenitors at their early stage of maturation. This 
effect of miR-9 is mediated by Stathmin, a protein that increases microtubule instability 
[397].  This discrepancy could be explained by the difference in the cellular context or 
some other unknown reasons.  
 
In addition, miR-9 targets Foxg1 to regulate the production of Cajal-Retzius cells 
in the medial pallium of the developing telencephalon [398].  Studies using miR-9-2 and 
miR-9-3 double–mutant mice demonstrate that miR-9 controls NSC proliferation and 
differentiation in the developing telencephalon by regulating the expression of Foxg1, 
TLX, Gsh2, and Meis2 [399].  In the developing brains of zebrafish, miR-9 is widely 
expressed in neural progenitor cells but is absent in the midbrain-hindbrain boundary 
(MHB).  A knockdown study demonstrated that miR-9 regulates the fibroblast growth 
factor signaling pathway by targeting Fgf8, Fgfr1, and Canopy1, and promotes 
progression of neurogenesis at the midbrain-hindbrain domain by inhibiting expression of 
bHLH transcription factor-encoding genes such as Her5 and Her9.  Together, these 




Lethal-7b (let-7b), a member of the let-7 microRNA family, has also been shown 
to regulate NSC fate determination [401].  let-7b is expressed in mammalian brains and 
exhibits increased expression during neural differentiation [395,402].  Overexpression of 
let-7b in NSCs inhibits proliferation and accelerates neuronal and glial differentiation, 
whereas antisense knockdown of let-7b promotes NSC proliferation [401].  Moreover, 
introducing TLX or cyclin D1-expressing vector, which lacks the let-7b binding site, 
rescued let-7b-induced NSC proliferation deficiency, suggesting that both TLX and 
cyclin D1 are key targets of let-7b in NSC [401].  let-7b has also been shown to target 
Hmga2, a member of the high-mobility group A (HMGA) family, to reduce NSC self-
renewal in the aging brain [403]. 
 
miR-124, one of the most abundant microRNAs in the adult brain [404], is also 
an important regulator of neurogenesis in both the developing spinal cord and in the adult 
SVZ [405,406].  A previous study demonstrated that the overexpression of miR-124 in 
HeLa cells suppresses the expression of 174 non-neuronal genes and promotes a mRNA 
profile more similar to that of neuronal cells [407].  Laminin γ1 and integrin β1, which 
are highly expressed in NSCs but repressed upon neuronal differentiation, were identified 
as endogenous targets of miR124 in the developing chick spinal cord [408].  In P19 
carcinoma cells and in embryonic stem cells, miR-124 was shown to mediate neuronal 
differentiation by antagonizing the anti-neural REST/SCP1 pathway [405], and switching 
on neuron-specific splicing by targeting PTBP1, a repressor of pre-mRNA splicing in 
non-neuronal cells [409].  In addition, the SRY-box transcription factor, Sox9, has also 
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been identified as a direct target of miR-124 in regulating neurogenesis and cell cycle exit 
in the SVZ stem cell niche [406].  More recently, Arvanitis et al. showed that miR-124 
forms a mutually repressive interaction with ephrin-B1 in the regulation of neuronal 
differentiation [410].  In summary, miR-124 promotes neuronal differentiation from 
NSCs through repressing various targets in a cellular context-dependent manner. 
 
Apart from miR-9, let-7b, and miR-124, miR-34a has also been shown to 
participate in the regulation of NSC differentiation.  miR-34a, a member of the miR-34 
family, is required for proper neuronal differentiation through targeting SIRT1 and 
modulating p53-DNA binding activity.  Overexpression of miR-34a increases the number 
of postmitotic neurons and promotes neurite elongation [411].    
 
miR-134 has been shown to interact with Sox2, a transcription factor expressed in 
NSCs.  Its levels are elevated between E11.5 and E17.5 during mouse cortical 
development [412].  Recently, miR-134 has been shown to promote the proliferation of 
cortical NSCs through its interaction with Doublecortin (Dcx) and/or Chordini-like 1 
(Chrdl-1) [413].   
 
The miR-106b~25 cluster, a member of miR-17 family, also promotes the 
proliferation and self-renewal of NSCs.  Knockdown of miR-25, but not miR-106b and 
miR-93, reduced NSC proliferation.  Interestingly, overexpressing the entire miR-
106b~25 cluster also enhances differentiation towards the neuronal lineage [414].  The 
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expression of the miR106b-25 cluster is regulated by FoxO3, a transcription factor that 
maintains NSC population [415].    
 
miR-137 has been shown to influence adult NSC proliferation and differentiation 
both in vitro and in vivo by targeting Ezh2, a histone methyltransferase and a member of 
the polycomb group (PcG) protein family.  miR-137 is subject to epigenetic regulation 
mediated by DNA methyl-CpG-binding protein (MeCP2) along with transcription factor 
Sox2.  Overexpression of miR-137 in NSCs promotes proliferation, whereas knockdown 
of miR-137 enhances differentiation[416].   
 
Other than miR-137, miR-184 is another microRNA subjected to epigenetic 
regulation in NSCs.  A recent study demonstrated that Methyl-CpG binding protein 1 
(MBD1), but not MeCP2, directly regulates the expression of miR-184 in adult NSCs.  
High levels of miR-184 enhance NSC proliferation and inhibit differentiation both in 
vitro and in vivo by targeting Numblike (Numbl) [417]. 
 
In summary, there is accumulating evidence that diverse members of the 
microRNA family are required in the maintenance of NSCs and the modulation of 






AIMS  OF  PROJECT 
 
Because of no unique and definitive markers, NSCs have not been purified or 
identified in vitro as a discrete cell type.  Currently NSCs are identified largely 
retrospectively, based on their functional properties such as self-renewal and 
multipotency.  While self-renewal is evaluated by the ability of the cells in the 
neurosphere to be passaged multiple times, multipotency is assessed by the ability of the 
neurosphere to differentiate into astrocytes, neurons and oligodendrocytes.  However, it is 
cumbersome to define NSC using such methods.  Most importantly, by the time we 
recognize it as such, the original NSC is lost as it has already divided and generated 
progeny, and is thus unavailable for study.  This significantly limits our ability to 
investigate the characteristics of NSCs.  Having a unique set of NSC markers would not 
only allow NSCs enrichment for in vitro studies, but also enable their identification in 
situ, which reveal their endogenous niches and behavior in vivo.  Hence, identification of 
NSC markers is a critical step towards making progress in understanding NSC biology, 
and it is the main aim of my project.  Notably, the neurosphere is composed of a 
heterogeneous mix NSCs, progenitor cells, and more differentiated cells.  Interrogating 
the mRNA of this mix of cells complicates the identification of NSC markers.  Single cell 
analysis provides a solution to this problem where distinct populations of cells within 
neurosphere can be followed and identified.  As such, the approach I adopted to achieve 





2 MATERIALS AND METHODS 
2.1 Animal Work 
2.1.1 Embryonic Brain Dissection and Dissociation 
 
The treatment of animals was performed according to the ethical guidelines for 
the Care and Use of Laboratory Animals of Institute of Medical Biology.  A time mated 
pregnant C57BL/6 mouse was anesthetized with intraperitoneal sodium pentobarbital 
(300 mg/kg) on embryonic day 14.5 (E14.5).  The day with a positive vaginal plug was 
defined as E0.5.  Cervical dislocation was performed to make sure the animal did not 
suffer pain and distress.  The anesthetized mouse was laid on its back and the abdomen 
was swabbed with 70% ethanol to sterilize the area.   
 
Using sterile instrument, an incision was made from the lower abdomen upward 
to the chest to expose the abdominal cavity and the uterine horns.  The uterus was 
dissected and transferred into a 50 mL conical tube containing cold HEM.  Under a sterile 
dissecting hood, the uterus was rinsed twice with fresh sterile cold HEM to remove 
possible contaminants like blood and hair.  The uterus was then transferred to a 10 cm 
Petri dish containing cold HEM.  Using small curved forceps and scissors, the embryos 
were collected from their individual sacs and were placed in a new 10 cm dish with cold 





The embryos were decapitated at a caudal level and the heads were transferred to 
another Petri dish containing cold HEM.  Under a dissecting microscope, the brain was 
removed from the skull with micro-scissors and fine curved forceps.  The overlying scalp 
tissue and the outer meninges were removed entirely to expose the forebrain and 
midbrain tissue.  Subsequently, with a pair of 45° angled forceps, the cerebral cortices 
were rapidly excised from the brain.  The dissected cortices were placed in a sterile 10 
cm Petri dish, and this procedure was repeated until all the brains had been micro-
dissected.   
 
Tissue pieces were transferred to a 15 mL centrifuge tube in 1 mL of NSC 
medium.  Tissue was then dissociated gently into single cells by pressing the 1 mL 
pipette tip to the bottom of the tube and pipetting the suspension up and down.  Pipetting 
was performed 3-4 times so that a milky like suspension was achieved.  Then, the 
suspension was allowed to settle for 1-2 minutes so as the non-dissociated clumps 
precipitates.  Almost the entire cell suspension was transferred to the other tube and then 
another 1 mL of NSC medium was added to the remaining clumps and dissociated to 
single cell as described.  The content of the tubes were pooled and centrifuged at 700 rpm 
for 5 minutes at room temperature.  After centrifugation, the supernatant was discarded 
and the cells were resuspended in 1 mL of complete NSC medium.  The medium was 
gently pipetted up and down to have a homogeneous single cell suspension.  Cell count 





2.2 Cell Culture 
2.2.1 Culture of Embryonic NSCs 
2.2.1.1 Plating of Embryonic NSCs 
 
The dissociated cells were plated at the density of 2 x 105 cells/mL into 10 cm 
culture dishes (NUNC) in complete NSC medium: Dulbecco’s Modified Eagle’s Medium 
(DMEM)/nutrient mixture F-12 (1:1) mixture medium (Invitrogen) containing 2% (v/v) 
B27 supplement (Invitrogen), 20 ng/mL basic fibroblast growth factor (bFGF; 
PeproTech), 20 ng/mL epidermal growth factor (EGF) (Invitrogen) and 1% 
penicillin/streptomycin (Invitrogen).  The cells were grown as suspension neurospheres 
for 5-7 days at 37oC in a 5% CO2 atmosphere in a humidified incubator.   
 
 
2.2.1.2 Passaging and Expansion of Embryonic NSCs 
 
Neurospheres were passaged by chemical dissociation.  When the neurospheres 
were ready for subculture (approximately 100 μm or less in diameter), the medium with 
suspended spheres was removed from the culture dish and placed in sterile tissue culture 
tube.  Neurospheres were collected by centrifugation at 1000 rpm for 1 min.  The 
supernatant was removed and the spheres were resuspended in 500 µL of NSC medium.  
Then, an equal volume of 0.05N sodium hydroxide (Sigma) was added to the cell 
suspension.  At the same time, the lab timer was set for 7 min.  At the 3-minute time 
point, the cell suspension was mixed gently by pipetting up and down 8 times using a 1 
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mL pipette tip.  The cell suspension was incubated until the 6-minute time point.  At the 
6-minute time point, again the cell suspension was pipetted gently up and down 8 times.  
At 7 min, 500 μL 0.05N hydrochloric acid (Sigma) was added immediately and the cell 
suspension was mixed by pipetting up and down 8 times.  Finally, 2 mL of complete NSC 
medium was added and viable cells were counted using Trypan Blue exclusion assay on a 
hemacytometer.  Dissociated cells were seeded at a density of 2 x 104 cells/mL for 
propagation.  In this study, cells within five passages were used for subsequent 
experiments. 
 
2.2.1.3 Freezing Embryonic NSCs 
 
Dissociated cells were grown as small neurospheres for two days at passage 2.  
Neurospheres were collected by centrifugation at 1000 rpm for 1 minute and resuspended 
in fresh NSC complete medium containing 10% DMSO.  The sphere suspension was then 
chilled on ice for 30 minutes, followed by aliquoting 1 mL into each polypropylene 
cryovials (Nunc).  The vials were placed in freezing chamber (Nalgene), and the chamber 
was kept in a -80°C freezer to allow the cells to freeze slowly.  On the next day, the vials 
were transferred to liquid nitrogen tank for long term storage.  
  
2.2.1.4 Thawing of Cryopreserved Neurospheres  
 
  The cryovial was removed from liquid nitrogen and thawed in 37°C water bath 
quickly.  The vial was swirled to speed thawing.  Cell suspension was then transferred 
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from the cryovial to a 15-mL centrifuge tube containing 5 mL of warm culture medium.  
Cell suspension was spun for 2 min at 1000 rpm.  The supernatant was removed.  Pellet 
was resuspended gently in fresh medium and plated in the culture dish. 
 
2.2.2 Neurosphere Formation Assay 
2.2.2.1 Low Density Culture 
 
Neurosphere formation assays were performed to assessing neurosphere numbers.  
Dissociated cells from neurospheres were labeled by incubating with selected antibodies.  
Unsorted, positive, and negative cells were plated at low-density (0.67 cell/µL) with a 
sorter FACSAria (Becton Dickinson) into 6-well low attachment plates (Costar).  The 
cells were analyzed after culturing for 5 days.  The total number of neurospheres in each 
well was determined.  Neurosphere Forming Units (NFUs) were calculated by expressing 
the number of neurospheres formed per 100 seeded cells.  Relative NFU is NFU 
normalized to that of control cultures.  Neurosphere size was evaluated using MetaMorph 
imaging software (version 6.1r1; Molecular Devices). 
 
For secondary neurosphere formation assay, neurospheres derived from C1qR1+ 
and C1qR1- cells were collected by centrifugation at 1000 rpm for 1 minute, and 
chemically triturated as described above.  Each pool of the cells was then reseeded under 





2.2.2.2 Clonal Culture 
 
Each cell population was sorted into 96-well ultra-low attachment plate (Costar) 
at a density of 1 cell per well.  Cultures were maintained at 37oC in a humid atmosphere 
with 95% oxygen and 5% CO2, and cells were fed every third day by adding fresh 
medium.  After 14 days in vitro, the number of single-cell-generated spheres was 
counted.  Individual clonal neurospheres were picked and differentiated as described in 
2.2.3.  
 
2.2.2.3 Serial Passaging 
 
To demonstrate extensive self-renewal property of NSCs, C1qR1-positive cells 
were sorted at low-density (0.33 cell/µL) into a low attachment 6-well plate containing 
growth medium.  Cells were then cultured for 5 days.  Neurospheres generated from 
C1qR1-positive cells were harvested, dissociated and a subset was replated at low-density 
(0.33 cell/µL) to form secondary neurospheres.  This process was repeated for 7 
passages.  The total neurospheres generated at each passage was calculated. 
 
2.2.3 NSC Differentiation 
 
For dissociated-cell differentiation, neurospheres were triturated into single cells 
as described above.  Cells were seeded onto 13 mm glass coverslips (Marienfeld) coated 
with laminin (10 µg/mL; Invitrogen) and poly-L-lysine (PLL) (10 µg/mL; Sigma) at a 
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density of 2 x 104 cells/coverslip. Cells were cultured in differentiation medium 
[Dulbecco’s Modified Eagle’s Medium (DMEM)/nutrient mixture F-12 (1:1) mixture 
medium, 2% (v/v) B27 supplement, 1% penicillin/streptomycin, and 0.5% fetal bovine 
serum (Invitrogen)] for 7 days.  
 
For single-neurosphere differentiation, individual neurospheres were picked under 
a microscope to a single well of a 50-well coverslips (Sigma) coated with PLL and 
laminin.  The neurospheres were allowed to attach to the coverslips in a humidified CO2 
incubator overnight.  In parallel, 3 x 106 dissociated NSCs were plated into a 10 cm 
culture dish (NUNC) coated with PLL and laminin in differentiation medium and 
incubated at 37oC overnight.  The following day, the 50-well coverslips with the attached 
single neurospheres were inverted onto the 10 cm dish containing differentiating cells.  
Special care was taken to ensure that spheres on the coverslips did not come into contact 
with the cells in the 10 cm dish.  Differentiating cells from the 10 cm dish served to 
condition the medium with neurotrophic factors that help to support differentiation of the 
single neurospheres on the coverslips.  Single neurospheres plated alone without such 
supporting cells either die or only give rise to astrocytes.  Control and treated spheres 




2.3 Transcript (mRNA) Analyses 
2.3.1 Total RNA Isolation  
 
Total RNA was extracted with Trizol reagent (Invitrogen) and purified with 
RNeasy Mini Kit (Qiagen).  Neurospheres were collected from a 10 cm tissue culture 
dish, containing approximately 1.5-2 million cells.  After centrifugation at 1000 rpm for 1 
minute, cells were homogenized with 0.8 mL Trizol reagent.  Homogenized cells in 
TRIZOL reagent were incubated for 5 minutes at room temperature to permit the 
complete dissociation of nucleoprotein complexes.  0.16 mL of chloroform was then 
added to the mixture followed by vigorous shaking with hands for 15 seconds.  Samples 
were centrifuged at 12,000 rpm for 15 min at 4°C.  The upper aqueous phase was 
transferred to a new RNase-free 1.5 mL tube.   RNA was precipitated by adding 350 uL 
of 70% room temperature Ethanol.  After mixing gently by inverting tube for 10 times, 
the resultant mixture was transferred into the spin column provided by RNeasy Mini Kit.  
The subsequent steps leading to RNA purification were performed in accordance with the 
manufacturer's instructions.  RNA concentration was determined using Nanodrop 
(Thermo Scientific). 
 
2.3.2 Formaldehyde Gel Electrophoresis of Total RNA  
 
To assess the integrity of total RNA, electrophoresis of the RNA sample was 
performed on a denaturing agarose gel stained with ethidium bromide.  RNA sample was 
denatured in a sterile RNase-free microcentrifuge tube by mixing the following: 10 µg of 
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RNA (in a final volume of 5 µL with DEPC-treated water), 2 µL of 10X MOPS solution, 
3.5 µL of formaldehyde, and 10 µL of formamide.  The RNA solution was incubated at 
65°C for 15 min in a fume hood and chilled on ice immediately.  After cooling, 2 µL of 
sterile RNA loading buffer was then added into the denatured RNA solution. 
 
1% agarose gel was prepared by heating 1 g agarose in 72 mL sterile RNase-free 
water until dissolved.  After cooling to 60oC, 10 mL of 10X MOPS running buffer [0.4 M 
MOPS (pH 7.0), 0.1 M sodium acetate, 0.01 M EDTA], 18 mL of 37% formaldehyde 
(12.3 M), and 10 µL of ethidium bromide solution (10 mg/mL) were added. Mix the 
components of the gel by gently rotating the bottle, being careful not to introduce any air 
bubbles. The gel was poured into the prepared casting tray with a comb and was allowed 
to set for a least 60 min at room temperature.  The gel was then assembled in the tank and 
covered by 1X MOPS running buffer. 
 
Heat denatured RNA samples were loaded into the wells and electrophoresed at 5-
6 V/cm until the bromophenol blue had moved approximately half to three quarters of the 
way along the gel.  RNA was visualized on a 254 nm short wave ultra-violet 
transilluminator. 
 
2.3.3 Primer Testing  




mRNA sequences were extracted from National Center for Biotechnology 
Information (NCBI) and primer sequences were designed using Primer3 (v.0.4.0) 
software available online (http://frodo.wi.mit.edu/primer3/).  For each gene, two sets of 
primers: one outer set and one nested primer set (within the outer primer product) were 
designed.  The criteria were that the primers were mostly 20 nucleotides long, had a 
maximum GC content of 50%, minimum end-region complementarities, and the melting 
temperature (Tm) of all the primers was between 55-60 oC.  All primers were purchased 
from Sigma-Proligo Pte Ltd (Singapore). 
 
2.3.3.2 Reverse Transcription (RT) 
 
Reverse transcription was performed on 1 μg of the extracted RNA per reaction to 
synthesize cDNA using Random primers (2.5μM) and dNTP (10mM) using M-MuLV 
Reverse transcriptase (New England Biolabs) in the presence of RNA-ase inhibitor 
(Rnasin 40U/μL from New England Biolabs).  The reaction sequence consisted of: 42oC 
for 60 min, 90 oC for 10 min and then it was chilled at -20 oC until further usage. 
 
2.3.3.3 Polymerase Chain Reaction (PCR) 
 
This cDNA (20 ng each) was used to carry out Polymerase Chain Reaction (PCR) 
using the specific primers (10mM), dNTP (5mM), Polymerase (0.25 μL each of 
HotStarTaq Polymerase 5U/μL from Qiagen), and 10X buffer (2.5 μL).  The final volume 
was made up to 25 μL with DEPC water. The optimized reaction sequence consists of: 
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denaturation at 95oC followed by 35 cycles of denaturation at 95oC, annealing at 55oC for 
30 sec and elongation at 72oC for 1 min, a final elongation at 72oC for 10 min before 
holding at 4oC. 
 
2.3.3.4 DNA Gel Electrophoresis 
 
To 10 μL each of the PCR product, 2 μL of DNA loading buffer was added.  The 
PCR products were loaded and electrophoresed on 2% agarose gel with 1X TAE and 
ethidium bromide.  A DNA ladder was also included so that the size of the amplified 
products could be determined.  The gel was then observed under UV light for presence of 
bands of the right size.   
 
If any of the amplification products do not show up, the primer is re-designed 
until a working primer is found.  Other remedies were to repeat the PCR but with the 
addition of Q-solution (Qiagen), changing the annealing temperature to 60oC and 
changing the buffer constituents. 
 
2.3.4 Single Cell RT-PCR 
2.3.4.1 Cell Sorting 
 
The single cell RT-PCR procedures were modified from those in previous reports 
(Fig. 2.1).  Neurospheres were collected and dissociated chemically into a single cell 
suspension.  The cells were then passed through a 40 µm filter and stained with 
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propidium iodide (Sigma).  Cells that stained negative for propidium iodide were FACS-
sorted into the 96-well PCR plates with each well containing 4 µL of cell lysis buffer 
[0.5% NP40, 5 mM DTT, and 5 U RNasin Plus RNase Inhibitor (Promega, USA)].  The 
number of the sorted cells per well is shown in the 96-well plate layout (Fig. 2.2).  The 
plates were then kept in -80oC freezer until used for further experiments.    
 
2.3.4.2 Reverse Transcription 
 
For single-stranded cDNA synthesis, the sorted plates were thawed in ice and a 
mixture consisting of 2.5mM dNTP Mix and an outer primer multiplex of seven genes 
including GAPDH (10mM of each primer set, Sigma-Proligo, Singapore) was added to 
each well.  After 1 min centrifugation, the mixture was heated at 70oC for 5 min, and the 
plates were immediately chilled on ice for 5 min.  A mixture consisting of 1 µL 10X RT 
Buffer, 0.5 µL of M-MuLV Reverse Transcriptase (New England Biolabs), 0.5 µL 
RNasin Plus RNase Inhibitor 40U/µL (Promega), and RNase-free water] was added to 
each reaction well.  The RT reaction mixture was incubated at 42oC for 60 min and heat-
inactivated at 90oC for 10 min.  5 µL of the synthesized RT product in each well was then 
loaded into a fresh 96-well PCR plate. 
 
2.3.4.3 Two Rounds of Polymerase Chain Reaction (PCR) 
 
For the first round of PCR, 25 µL of PCR mixture [2.5 µL 10X buffer, 0.5 µL of 
10 mM dNTP Mix, and 0.5 µL of Hotstar Taq 5U/µL (Qiagen)] was added to each well.  
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The PCR was performed according to the following conditions: An initial denature 
temperature of 95oC for 15 min, 35 cycles of 95oC for 30 sec, 55oC for 30 sec, 72oC for 1 
min, and a final elongation of 10 min at 72oC.  1µL of the PCR product was then 
introduced into a fresh 96-well plate for the second round of PCR.  Another 25 µL of 
PCR mixture was added, with a composition same as previous PCR mixture but with 
nested primers specific for one gene replacing a primer multiplex.  A 35-cycle PCR 
amplification with same cycling conditions as the first round of PCR was performed 
again.  The PCR products were then electrophoresed on 2% agarose gel and visualized 
with ethidium bromide staining under UV light.  The whole process was repeated until 
each gene was tested on 500 cells.   
 
2.3.4.4 Calculation of Percentage Expression 
 
The percentage expression of a gene was calculated as follows: 
Percentage of expression  

















                                                                              
 
                                                                              
                                                                                     
                                                     
                                                                                                            
 
 
                                                                               
 












                           Figure 2.1    Schematic of single cell RT-PCR process. 
Dissociated E14.5 cortical neurosphere cells 
96-well PCR plate containing 4 µL of lysis buffer 
Primed reverse transcription 
Round 1 PCR 35 cycles 
Round 2 (Nested) PCR 35 cycles 
DNA gel electrophoresis 
Primer multiplex 
5 µL RT mixture 













              Figure 2.2    96-well plate layout showing number of single cells from     





2.3.5 Quantitative (Real-time) RT-PCR Gene Expression Analysis 
 
Cells were FACS-sorted into 96-well PCR plate containing reverse transcription 
reaction mix [gene specific primers (TaqMan®), CellsDirect reaction mix (Invitrogen), 
SuperScriptTM III RT/Platinum® Taq mix (Invitrogen)] to pre-amplify genes of interest.  
After sorting, cells were freezed and thawed to induce cell lysis.  The reverse 
transcription reaction [50oC for 20 minutes, followed by 17 cycles of 95oC for 15 seconds 
and 60oC for 4 minutes] was then carried out to generate cDNA.   
 
The pre-amplified cDNA were diluted and used as template for each reaction in 
real-time quantitative PCR analysis, using TaqMan® Universal PCR Master Mix in an 
Applied Biosystems 7500 Fast Real-Time PCR System.  TaqMan® MGB probes for each 
candidate gene were designed and synthesized by Applied Biosystems.  The following 
gene expression assays were performed: β-actin (Mm00607939_s1), nestin 
(Mm00450205_m1), Pax6 (Mm00443081_m1), Sox2 (Mm03053810_s1), Hes1 
(Mm01342805_m1), Hes5 (Mm00439311_g1), Musashi1 (Mm00485224_m1), and 
FoxG1 (Mm02059886_s1).  For each primer pair, duplicates of three independently 
collected samples were compared to quantify relative gene expression differences 
between these cells.  The Ct threshold value was determined by using the automatic 
baseline determination.  All expression values were normalized against β-actin and the 
relative expression of the genes was determined by using the expression 2-∆Ct.  The fold 




2.3.6 Microarray Analysis 
 
Total RNA was harvested as above from primary neurospheres.  RNA 
concentrations were determined by Nanodrop (A260/280-1.8) and RNA quality was 
further evaluated using an Agilent Bio-Analyzer.  0.5 μg total RNA was then subjected to 
reverse transcription, second strand cDNA synthesis and in vitro transcription (to amplify 
RNA), using Illumina TotalPrep RNA Amplification kit (Ambion, USA, Cat#: IL1791).  
The resultant amplified RNAs were hybridized on Sentrix® Mouse Ref-8 v2 Expression 
BeadChip (Illumina, USA, Cat#: BD-202-0202), washed and scanned with Illumina 
BeadStation according to the Illumina protocols. 
 
The scanned results were put through Beadstudio software (Illumina) in order to 
obtain background normalized data before exporting into the Partek format and analysed 
using Partek Genomic Suite’s Gene Expression Data Analysis (Partek, USA).  The data 
was then subjected to normalization according to biological sample batches using the 
‘batch remove’ function, and analyzed for gene expression changes with p-value less than 
0.05 using ANOVA statistical test. 
 
2.4 Protein Work 
2.4.1 Fluorescent Activated Cell Sorting (FACS) 
 
Acutely dissociated cortical cells from E14.5 embryos or primary neurosphere 
dissociated cells were resuspended in Hank’s Balanced Salt Solution (HBSS) and 
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blocked with 3% bovine serum albumin (Sigma) for 15 min at room temperature.  Cells 
were then filtered through cell strainer caps (40-µm mesh; BD Biosciences) and brought 
to a concentration of 0.5-2.0 x 106 cells/mL.  Surface antigens were labeled by incubating 
with selected antibodies that had been directly conjugated to a fluorochrome for 15 min at 
room temperature in dark.  The selected antibodies were against mouse Prom1 (APC 
conjugated, Miltenyi Biotec), mouse LeX (FITC conjugated, R&D System), mouse c-Kit 
(PE conjugated, BD Pharmingen), mouse End (PE conjugate, eBioscience) and mouse 
C1qR1 (PE conjugated, R&D System).  Isotype-matched mouse immunoglobulin served 
as controls.  All washing steps were performed in cold phenol-free, Ca2+-free, Mg2+-free 
Hank’s Balanced Salt Solution containing 1% penicillin/streptomycin and 2% (v/v) B27 
supplement (all from Invitrogen). 
 
The stained cells were analyzed and sorted on a fluorescence activated cell sorter 
FACSAria (Becton Dickinson) using FACSDiva software (Becton Dickinson); data were 
additionally analyzed and presented using FlowJo software.  The fluorochromes were 
excited with the instrument’s standard 488-nm, 561-nm, and 633-nm lasers.  
Fluorescence was determined by analysis and gating against appropriate controls 
prepared in parallel.  Dead cells were excluded by propidium iodide (Sigma) staining. 
Debris and aggregated cells were excluded based on forward and side scatter of control 
samples.  Prior to aseptic sorting, the nozzle, sheath, and sample lines were sterilized with 
70% ethanol for 15 minutes, followed by washes with sterile water to remove remaining 
decontaminant. A 100-µm ceramic nozzle (BD Biosciences), sheath pressure of 20-25 
84 
 
PSI, and an acquisition rate of 1,000 events per second were used as conditions optimized 




Cells were fixed in 4% paraformaldehyde for 20 min at room temperature.  After 
rinsing with phosphate-buffered saline (PBS) and preincubation in a mixture of 5% 
normal goat serum and 0.5% Triton X-100 in PBS, cells were immunostained with the 
primary antibodies overnight at 4°C. The following proteins were evaluated: anti-βIII-
tubulin (mouse monoclonal, 1:500; Covance), anti-O4 (mouse monoclonal, 1:500; 
Chemicon), and anti-GFAP (rabbit polyclonal, 1:1000; Dako).  In the case of anti-O4, 
Triton X-100 was excluded from the incubation buffer, since it recognizes cell surface 
glycoprotein.  Subsequently, after repeated rinses in PBS, the cells were incubated with 
the secondary antibody Alexa Fluor 488 goat anti-mouse (1:500; Molecular Probes) for 2 
hours at room temperature.  For nuclei staining, cells were incubated for 5 min in 4’-6-
diamidino-2-phenylindole (DAPI) (Invitrogen).  Immunocytochemistry was also 
performed by omitting the incubation with primary antibodies as negative controls.  
Coverslips were mounted with Hydromount (National Diagnostics) and allowed to dry 
overnight at room temperature, prior to imaging.  Stained cultures were examined and 
photographed by a Zeiss AxioImager Z1 wide field fluorescence microscope with 




For triple staining of differentiated single neurospheres, sequential staining was 
performed with mouse IgM anti-O4 (1:300; Chemicon) for 2 hours at room temperature, 
followed by Alexa Fluor 488 goat anti-mouse IgM (1:500; Molecular Probes) for 1 hour.  
Cells were then permeabilized with 0.5% triton-X 100, followed by simultaneous staining 
with mouse anti-Tuj1 (βIII-tubulin) IgG2a (1:250; Covance) and rabbit anti-GFAP IgG 
(1:1000; Dako) for 2 hours at room temperature.  The secondary antibodies used were 
Alex Fluor 594 goat anti-mouse IgG2a and Alexa Fluor 647 donkey anti-rabbit IgG 
respectively (1:500; Molecular Probes).  Finally, cells were counter-stained with DAPI 
and mounted for viewing.  Images were taken with the Zeiss Axioimager Z1 wide field 
fluorescence microscope. 
 
To evaluate multipotency properties, 100 neurospheres were examined.  The 
number of tripotent, bipotent, and unipotent neurospheres were quantified and expressed 




Embryonic brains were dissected from E14.5 litters obtained from pregnant mice.  
Coronal brain sections, 10-20 µm thick, were cut on a cryostat and mounted directly onto 
PLL-coated slides.  The sections were air-dried at room temperature for 30-60 min and 
subsequently fixed with 1:1 ice-cold methanol-acetone mixture for 10 min at -20°C.  
After being blocked with 10% normal goat serum (Invitrogen) and 1% bovine serum 
albumin (Sigma), sections were incubated with primary antibodies overnight at 4°C.  The 
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antibodies against the following antigens were used: nestin (chicken polyclonal antibody, 
1:500, Novus Biologicals), LeX (mouse monoclonal antibody, 1:200; BD Biosciences), 
and C1qR1 (mouse monoclonal antibody, 1:200; Millipore).  Preincubation with a 10-
fold excess of specific blocking peptide (1st Base, Singapore) against C1qR1 antibody 
was used as a negative control for this reaction.   
 
The following day, the sections were washed several times with PBS and 
incubated with anti-chicken Alexa Fluor 488 IgG and anti-mouse Alexa Fluor 568 IgG 
(1:1000; Molecular probes) secondary antibodies for 1 h at room temperature.  The 
sections were counterstained with DAPI (Invitrogen).  Fluorescent mounting media was 
applied before placing coverslips onto the slides.  Nail polish was applied along the edges 
of the coverslips to seal them to the slides.  The cells immunoreactive for C1qR1, LeX, 
and nestin were examined under Olympus FV1000 confocal microscope. 
 
2.5 Cell Cycle Analysis 
 
A single cell suspension containing approximately 1 million cells was incubated 
with antibody against mouse C1qR1 (PE conjugated, R&D System) for 30 min at 4oC in 
dark.  After repeated washing, cells were resuspended in 1.2 mL PBS in a 15 mL 
polypropylene tube.  3 mL of ice cold absolute ethanol was added drop-wise while 
vortexing gently.  The cell suspension was fixed in this final 70% ethanol solution for at 
least 2 hours on ice.  The ethanol/cell suspension was then diluted with 10 mL PBS 
followed by centrifugation at 2200 rpm for 10 min.  Ethanol was decanted thoroughly 
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and the cells were washed again in PBS.  Finally, cell pellet was resuspended in 1 mL 
DAPI staining solution (10 µg/mL DAPI and 0.1% Triton-X 100 in PBS) and incubated 
for 30 min in the dark at room temperature.  Cell cycle analysis was carried out on a LSR 
II flow cytometer (Becton-Dickinson).  Pulse-width/pulse-area signal was used to 
discriminate between G2/M cells and the cell doubles.  The data was analyzed using 
Flowjo software (Tree Star, Inc). 
 
2.6 Statistical Analysis 
 
All experiments were done in a minimum of 3 times.  Statistical comparison of 
datasets was performed by two-tailed paired Student’s t test.  P-values are denoted in the 







3.1 Establishment of single cell RT-PCR analysis  
 
To identify putative NSCs, I decided to carry out single cell analysis of cells 
grown in neurosphere cultures.  Embryonic neurosphere-derived cells were collected 
from cultures passaged less than 5 times and sorted into 96-well PCR plates.  A total of 
51 genes were analyzed with RT-PCR on a total of 500 single cells.  These genes include 
housekeeping, stem cell-related, progenitor-related, cell surface receptor, and genes of 
interest selected from microarray data (Table 3.1).  Our multiplex PCR permitted the 
amplification of seven targets of interest within one reaction by using multiple primer 
pairs.  Bulk neurosphere RNA was isolated using Trizol reagent and RNeasy Mini Kit.  
Electrophoresis of total RNA was performed under denaturing conditions to assess the 
integrity of RNA.  Formaldehyde was used as a denaturant within the agarose gel.  The 
RNA appeared as two bright distinct bands that represent the 28S and 18S ribosomal 
RNA.  The 28S/18S RNA bands had an intensity ratio around two, indicating that the 






Table 3.1    Genes selected for analysis with single cell RT-PCR.   
 
  
Gene Encoded protein %  cells Selection 
Egfr epidermal growth factor receptor 80.2 Control 
Hprt-1 hypoxanthine guanine phosphoribosyl 
transferase 
91.6 Control  
Gapdh glyceraldehyde-3-phosphate dehydrogenase 92.7 Control 
 
Tubb3 tubulin, beta 3 0.0 Neuron related gene 
NgR Nogo receptor 33.4 Neuron related gene 
Neurod1 neurogenic differentiation 1 36.6 Neuron related gene 
Nrxn1 neurexin I 53.0 Neuron related gene 
Ncam2 neural cell adhesion molecule 2 54.0 Neuron related gene 
Ncam1 neural cell adhesion molecule 1 72.5 Neuron related gene 
Olig1 oligodendrocyte transcription factor 1 0.9 Oligodendrocyte related 
gene 
GalC galactosylceramidase 53.3 Oligodendrocyte related 
gene 
S100b S100 protein, beta polypeptide, neural 1.7 Astrocyte related gene 
Gfap glial fibrillary acidic protein 10.8 Astrocyte related gene 
 
CD34 CD34 antigen 0.0 Cell surface receptor 
Eng endoglin 4.5 Cell surface receptor 
CD10 membrane metallo endopeptidase 1.0 Cell surface receptor 
Prom1 prominin 1 7.4 Cell surface receptor 
c-KIT proto-oncogene tyrosine-protein kinase Kit 9.9 Cell surface receptor 
C1qR1 complement component 1 q subcomponent 
receptor 1 
14.0 Cell surface receptor 
Abca2 ATP-binding cassette, sub-family A 
(ABC1), member 2 
23.8 Cell surface receptor 
CD90 thy-1 membrane glycoprotein 55.0 Cell surface receptor 
Abca3 ATP-binding cassette, sub-family A 
(ABC1), member 3 
61.0 Cell surface receptor 





Sox1 transcription factor SOX-1 0.0 Stem cell related 
Crtap cartilage associated protein 2.3 Stem cell related 
Bysl bystin-like 10.9 Stem cell related 
LeX fucosyltransferase IV 17.5 Stem cell related 
Tead2 TEA domain family member 2 23.3 Stem cell related 
Gab1 GRB2-associated binding protein 1 24.0 Stem cell related 
Sox2 transcription factor SOX-2 28.0 Stem cell related 
Ccnd1 cyclin D1 31.5 Stem cell related 
Hes6 hairy and enhancer of split 6 34.9 Stem cell related 
Notch1 neurogenic locus notch homolog protein 1 35.2 Stem cell related 
Ppic peptidylprolyl isomerase C 48.2 Stem cell related 
Sdc1 syndecan 1 56.5 Stem cell related 
Msi1 Musashi homolog 1 59.9 Stem cell related 
Metrn meteorin, glial cell differentiation regulator 80.5 Stem cell related 
Tnc tenascin C 81.8 Stem cell related 
Nes nestin 86.2 Stem cell related 
Rcn1 reticulocalbin 1 89.8 Stem cell related 
Vim vimentin 93.5 Stem cell related 
 
Ptrf polymerase I and transcript release factor 1.0 Gene microarray 
Oprl1 opioid receptor-like 1 2.0 Gene microarray 
Smad1 SMAD family member 1 26.0 Gene microarray 
Megalin low density lipoprotein receptor-related 
protein 2 
30.0 Gene microarray 
Epha2 Eph receptor A2 34.0 Gene microarray 
Jag1 jagged 1 50.0 Gene microarray 
Il6st interleukin 6 signal transducer 51.5 Gene microarray 
Sgce sarcoglycan, epsilon 52.3 Gene microarray 
Itgb1 integrin beta 1 55.0 Gene microarray 














Figure 3.1    Good quality total RNA. 
 
Ethidium bromide stained agarose gel of total cellular RNA isolated from bulk 
neurospheres.  RNAs were extracted with TRIZOL Reagent and Purified with QIAGEN 
RNeasy Mini Kit.  The arrows indicate the 28s and 18s bands that represent the 
characteristic ribosomal RNAs.  The intensity ratio of these two bands (28S/18S) is 







All primers used in this study were designed using Primer3 (v.0.4.0) software.  To 
enhance amplification specificity and minimize the carry-over of primer dimers from the 
first round of PCR, internal (nested) primers were used in the second PCR rounds.  To 
validate all the primers, RT-PCR was carried out with 1 µg of total RNA using individual 
primers.  PCR products were run in a 2% agarose gel and stained with ethidium bromide. 
As seen in the Figure 3.2A, both outer primer and nested primer for Egfr, Gapdh, LeX, 
and Notch1 were functioning properly.  Primers for the remaining genes were also 
functional but the gel electrophoresis image was not included.  In addition, the 
compatibility of primer pairs from two different genes was also tested.  Product bands 
from both primers have to be present to indicate compatibility for use in a multiplex 
format.  As seen in Figure 3.2B, only one band was present in lanes 1, 2, 5, and 6.  The 
missing band was the PCR product of the primer that could not work in combination with 
the other primer.  Primers for Eng and LeX were therefore redesigned.   
 
To assess the efficiency of single cell RT-PCR analysis, Gapdh, Egfr, and Hprt-1 
were used as control genes.  Repeats of any single plate yielded highly consistent results 
















Figure 3.2    Primers used in this study are functioning properly. 
 
A) RT-PCR was carried out with 1 µg of total RNA to validate the primers.  The outer 
primer and the nested primer of each gene are functioning properly.  B) Primer pair 
compatibility test. Product bands from both primers have to show up to indicate 
compatibility for use in a multiplex. 
  
Outer primer product 
Nested primer product 
Egfr Gapdh LeX Notch1 
Gapdh 
1 2 3 4 5 6 7 8 9 10 
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Figure 3.3    Single cell RT-PCR is reproducible. 
  
A) Gel electrophoresis image of single cell RT-PCR products for housekeeping genes in 
10 cells, 5 cells, and single cell.  B) Summary of percentage of single cells expressing 
transcripts for each housekeeping gene.  Variability is slight between PCR plates but 



























3.2  Identification of C1qR1 as a potential NSC marker 
 
  The final single cell RT-PCR products were separated on a 2% agarose gel and 
observed under UV light for the presence of bands.  The percentage expression of each 
gene was calculated from analyzing just the single cells.  The 10-cell and 5-cell columns 
were not used in the calculation process.  The percentage of cells expressing genes 
encoding a variety of cell surface receptors was shown in Figure 3.3 (a full list of the 51 
genes examined by single cell RT-PCR was given in Table 3.1).  Oligodendrocyte 
markers (Olig1 0.9% and Galc 53.3%) were expressed within the neurosphere.  Similarly, 
a small percentage of cells also expressed astroglial markers (Gfap 10.8% and S100b 
1.7%).  Neuronal markers (Nrxn1 53% and Ncam1 72.5%) have an unexpectedly 
moderate amount of expression within neurosphere cells.  Besides, Sox1, CD34, and 
Tubb3 were not detected in single cells, groups of 5 cells or groups of 10 cells.  
Interestingly, genes commonly believed to be NSC markers, such as nestin and 
Musashi1, expressed in 86.2% and 59.9% of cells in a neurosphere, respectively, 
suggesting that they were also expressed in neural progenitors.  
 
On the basis of our neurosphere assay results under different growth conditions, I 
used an arbitrarily set upper limit for neurosphere formation of 20% for selection of 
potential NSC surface markers.  Following this guideline, I had identified a set of 5 genes 
encoding cell surface receptors; Eng, c-KIT, Prom1, LeX, and C1qR1, which expressed 
at 4.5%, 9.9%, 7.4%, 17.5%, and 14.0% of the cell population, respectively (Fig. 3.4).  Of 

















Figure 3.4    Result of single cell RT-PCR. 
 
A) Gel electrophoresis pictures of the sample SC RT-PCR products.  Gapdh which is a 
housekeeping control gene is present in all the cells.  B) Summary of percentage of single 
cells expressing transcripts for each gene.  500 cells were tested for each gene.  Genes 

























To determine whether LeX, Prom-1, Eng, c-KIT, and C1qR1 selection may be 
useful for NSC enrichment, neurosphere formation assays were performed.  Single cell 
suspension obtained from dissociated neurospheres was stained with anti-LeX, anti-Eng, 
anti-c-KIT, anti-Prom1, and anti-C1qR1.  After staining, positive and negative cells for 
each marker were sorted by FACS into the 6-well plate containing growth medium at 
density of 0.67 cells/µL.  A control corresponding to unsorted live cells was passed 
through the FACS and isolated.  Neurosphere formation for LeX, Prom1, and C1qR1 
positive cells was significantly higher than that for control cells as well as that for 
negative cells (Fig. 3.5).  These purified populations generated neurospheres in vitro at 
2.5, 1.7, and 2.4–fold enrichment, respectively, compared with the control cells.  In 





       
            
         
 








Figure 3.5    Selection of cells with LeX, Prom1, and C1qR1 increases neurosphere 
formation.  
 
Cells obtained from dissociated neurospheres were stained with anti-LeX, anti-Eng, anti-
c-KIT, anti-Prom1, and anti-C1qR1.  Positive and negative cells for each marker were 
FACS-sorted at 0.67 cell/µl into the culture medium containing EGF and bFGF, and the 
number of neurospheres forming was counted 5 days later.  “Unsorted cells” refers to 
sorting live cells with no gating on any marker (Mean ± SEM; n =3; * P ≤ 0.05, ** P ≤ 




































3.3 Characteristics of C1qR1 selected cells 
 
To ascertain whether C1qR1 positive cells exhibit the characteristics of NSCs, 
their proliferative potential, self-renewal, and multipotency were next examined.  Cell 
cycle analysis was carried out to evaluate the proliferative potential of C1qR1+ cells.  
Dissociated cells were stained with DAPI and analyzed by flow cytometer to determine 
their DNA content.  Using this approach, cells can be assigned to G0/G1, S, or G2/M 
phases of the cell cycle.  Flow cytometry analysis indicated that greater fraction of 
C1qR1+ population was undergoing DNA synthesis and mitosis as compared with 
C1qR1- population.  For C1qR1+ population, 51.3% were in G1/G0, while 48.2% were 
in S-G2/M.  Conversely, for C1qR1- population, 88.8% were in G1/G0 and 7.2% were in 
S-G2/M (Fig. 3.6).  Therefore, C1qR1+ cells appeared to be a rapidly cycling population 
compared with C1qR1- cells.  Next, I categorized the neurospheres generated from both 
populations into three size groups (<50 µm, 50-100 µm, and >100 µm).  Analysis 
demonstrated that the majority (85%) of neurospheres generated from C1qR1+ cells were 
larger than 50 µm and 27% larger than 100 µm.  In contrast, only 35% of neurospheres 
generated from C1qR1- cells were larger than 50 µm and none were larger than 100 µm 






Figure 3.6    C1qR1+ cells appeared to be a rapidly cycling population compared with C1qR1- cells. 
 
Cell cycle analysis of neurosphere dissociated cells stained with anti-C1qR1-PE.  DAPI was used to separate the cells 
according to their cell-cycle status (G0/G1 phases form S-G2/M phases).  Analysis gates were set as illustrated in (A).  The 
C1qR1+ and C1qR1- cells are colored blue and red respectively.  Ungated cells are colored black.  The cell cycle profile of 
each population is illustrated in (B) and (C). 




       
                                                                                                                                                                    
               
                          





       
   
 
                                                            
     
 
 
Figure 3.7    C1qR1+ neurospheres are larger than C1qR1- neurospheres. 
 
Images of neurospheres generated from C1qR1+ cells (A) and C1qR1- cells (B).  4x 
magnification.  Scale bar = 100 µm.  The diameter of neurospheres generated from 
C1qR1+ and C1qR1- cells were measured and divided into three categories, < 50 µm, 50-
100 µm, and > 100 µm.  The bar chart shows the percentage of neurospheres in each size 































To assess the self-renewal capacity, neurospheres generated from C1qR1+, 
C1qR1-, and unsorted cells were evaluated for their secondary neurosphere formation. 
Single cells sorted from each population were allowed to form neurospheres for 5 days at 
0.67 cell/µL, dissociated into single cells, and re-plated at 0.67 cell/µL for another 5 
days. Cells from C1qR1+-derived neurospheres gave rise to 6-fold higher number of 
secondary neurospheres compared with cells from C1qR1- -derived neurospheres (Fig. 
3.8A).   
 
Secondary neurosphere formation is not a good indicator for self renewal since 
progenitors are also known to have limited self-renewal capacities.  Hence, it is necessary 
to demonstrate long-term self-renewal by serial passaging.  Neurospheres generated from 
C1qR1+ cells were harvested, dissociated into single cells, and replated for another 5 
days to form secondary neurospheres.  C1qR1+ cells were found to be able to passage for 
at least seven passages (Fig3.8B).  
 
 To evaluate the multipotency of the neurospheres, differentiation of cells as a bulk 
population was performed.  5-day-old neurospheres generated from C1qR1+ cells were 
pooled, dissociated and differentiated with 0.5% FBS.  Cells from the neurospheres 
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Figure 3.8    Self-renewal characteristic of C1qR1+ cells. 
 
A) Unsorted, C1qR1+, and C1qR1- cells were plated at 0.67 cell/µL and neurosphere 
formation followed for 5 days.  Neurospheres were then collected and triturated into 
single cells and re-seeded at 0.67 cell/µL.  The number of secondary neurospheres 
formed was counted 5 days later (Mean ± SEM; n =3; *** P ≤ 0.001).  B)  C1qR1+ cells 






















































   
 
    
 
    





Figure 3.9    Bulk populations of cells dissociated from C1qR1+-derived neurospheres are multipotent. 
 
Neurospheres were dissociated and differentiated for 7 days. Cells were stained for GFAP (A; green), O4 (B; green), ß-tubulin (C; 
green), and counterstained with DAPI (blue).  20x magnification.  Scale bar = 500 µm.
A) B) C) 
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3.4 C1qR1 expression in brain tissue  
 
To study the localization of C1qR1 in developing embryonic brain cortex, I 
performed immunohistochemistry analysis.  During development, NSCs/NPs reside 
predominantly in the ventricular (VZ) of embryonic cortex from day 10.5-14.5.  I found 
that C1qR1 is localized throughout both the VZ and SVZ with stronger expression in the 
apical VZ.  There were occasional intense C1qR1 positive cells in the SVZ or VZ as 
shown in Figure 3.10C and F.  C1qR1 colocalized with nestin and LeX in the embryonic 
cortex (Fig. 3.10D and H) suggesting it is expressed in NSCs in vivo.  In order to test the 
specificity of the C1qR1 monoclonal antibody to its antigen in the embryonic cortex, I 
blocked the antibody to peptide antigen in nM excess.  The blocking experiments showed 
that the monoclonal antibody against C1qR1 is specific for its antigen. 
 
If C1qR1 is a marker for NSCs it should enrich for NFUs from dissociated E14.5 
brain tissue.  To examine this possibility cells obtained from freshly dissociated E14.5 
brain tissue were labeled with PE-C1qR1 and then sorted with a flow cytometer.  Sorted 
cells were cultured at low density (0.67 cell/µL) in serum-free growth medium containing 
bFGF and EGF.  C1qR1+ cells formed more neurospheres than the control and C1qR1- 
cells.  The NFUs of C1qR1+ cells was 2.1-fold higher that of unsorted cells and 2.5-fold 










Figure 3.10    C1qR1 is localized throughout both the VZ and SVZ in developing embryonic brain cortex. 
 
Embryonic brain secrtions were stained for nestin, LeX, C1qR1, and counterstained with DAPI.  C1qR1 colocalized with nestin (D) 
and LeX (H) in the embryonic cortex suggesting it is expressed in NSCs in vivo.  12 brain slices were performed from 3 experiments.  


















                                                  
Figure 3.11    C1qR1+ cells in primary brain tissue also efficiently form neurospheres. 
 
Cells obtained from freshly dissociated embryonic brain were stained with anti-C1qR1-
PE.  Unsorted, C1qR1+, and C1qR1- cells were sorted and plated at 0.67 cell/µL.  The 
number of primary neurospheres formed in the presence of EGF and bFGF was counted 5 


















To verify that C1qR1+ cells from E14.5 brain cells possess the NSC phenotype, 
primary neurospheres were dissociated into single cells and cultured for 5 days.  
Formation of secondary neurospheres demonstrated their self-renewal capacity (Fig. 
3.12).  Next, secondary neurospheres were dissociated and differentiated by plating onto 
Poly-L-Lysine/laminin–coated coverslips.  To induce differentiation, growth factors were 
removed from the growth medium and the medium was supplemented with 0.5% FBS.  
Adherent cells displayed distinct morphologies consistent with their expression GFAP, β-
tubulin, or O4 (Fig. 3.13).  Hence, C1qR1 enriches for self-renewing, multipotent 
neurosphere forming cells from primary E14.5 brain tissue. 
 
3.5 C1qR1 is comparable with LeX and Prom1 as a neural stem cell marker 
 
To evaluate the usefulness of C1qR1 for the isolation of neural stem cells, I 
compared C1qR1 with the other two known markers, LeX and Prom1, based on neural 
stem cell frequency analysis.  I first examined the neurosphere formation.  Cells obtained 
from dissociated neurospheres were stained with anti-C1qR1, anti-LeX, and anti-Prom1.  
Unsorted, C1qR1+, C1qR1-, LeX+, LeX-, Prom1+, and Prom1- cells were sorted and 
plated at clonal density (1 cell/well) into 96-well plate.  Clonal density was applied in 
order to exclude the possibility of aggregation, which would also affect the multipotency 
assay.  Percentage of neurosphere formation for each population was determined after 14 
days.  Cells from C1qR1+, LeX+, and Prom1+ populations formed more neurospheres at 
43.0%, 42.33%, and 29.34% respectively.  Unsorted cells formed neurosphere at 15.25% 






            
 





Figure 3.12    C1qR1+-derived neurospheres form more secondary neurospheres. 
  
Neurospheres generated from unsorted, C1qR1+, and C1qR1- cells were collected and 
dissociated into single cells and seeded at 0.67 cell/µL in the growth medium.  Secondary 









































Figure 3.13    C1qR1+ cells are able to give rise to three lineages, demonstrating their multipotency. 
 
Neurospheres were dissociated and differentiated for 7 days. Cells were stained for GFAP (A; green), O4 (B; green), β-tubulin (C; 
green), and counterstained with DAPI (blue).  20x magnification.  Scale bar = 500 µm. 













Figure 3.14    Neurosphere formation of C1qR1+ cells is comparable to that of LeX+ and 
Prom1+ cells. 
 
Cells obtained from dissociated neurospheres were stained with anti-C1qR1, anti-LeX, 
and anti-Prom1.  Unsorted, C1qR1+, C1qR1-, LeX+, LeX-, Prom1+, and Prom1- cells 
were sorted and plated at 1 cell/well into 96-well plate.  The number of neurospheres 
formed in the presence of EGF and bFGF was counted 14 days later (Mean ± SEM; n =3; 
























Next, individual clonal neurospheres derived from each population were picked, 
differentiated, and stained for markers of the three lineages (neuron, astrocyte, and 
oligodendrocyte).  An example of a tri-lineage staining analysis is shown in Figure 3.15.  
The number of differentiated neurospheres staining for the three markers of NSCs 
differentiated cell types was scored and presented as percentages (Fig. 3.16).  12.24% of 
the unsorted cell-derived neurospheres were multipotent, differentiating into cells 
staining for GFAP, β-tubulin and O4; 22.45% were bipotent (GFAP and β-tubulin); and 
65.31% were unipotent (GFAP only).  With C1qR1 selection, 67.71% were multipotent, 
26.05% were bipotent, and 6.25% were unipotent.  Only 9.08% of the neurospheres 
derived from C1qR1- cells were multipotent.  With LeX selection, 59.58% were 
multipotent, 22.34% were bipotent, and 18.09% were unipotent.  With Prom1 selection, 
70.29% were multipotent, 13.21% were bipotent, and 16.50% were unipotent.  
Interestingly, neurospheres generated from Prom1- cells also demonstrated high 
multipotency, where 60.0% of the neurospheres were multipotent.  
 
Neural stem cell frequency was estimated by equating it to the product of 
percentage of neurosphere formation and percentage of multipotent neurospheres (NSC 
frequency = % neurosphere formation x % multipotent neurosphere).  The NSC 
frequency that I have estimated was 2.0% for unsorted cells, 29.12% for C1qR1+ cells, 





                                     






Figure 3.15    Triple-staining of differentiated neurospheres.  
  
Single neurospheres were picked and differentiated in a 50-well coverslip for 4 days. 
Cells in the sphere were stained for O4 (A; green), ß-III tubulin (B; red), GFAP (C; grey).  
Overlay of all three fluorescence (D).  20x magnification.  Scale bar = 100 µm. 
 











Figure 3.16    Neurospheres generated from C1qR1+ cells have similar multipotency to LeX+ and Prom1+ cells.  
 
Neurospheres generated from unsorted, C1qR1+, C1qR1-, LeX+, LeX-, Prom1+, and Prom1- cells were differentiated as 
single neurospheres.  Differentiated neurospheres were stained and scored according to the presence of the cell type markers 





























Figure 3.17    C1qR1 is comparable with LeX and Prom1 as a NSC marker. 
 
NSC frequency was estimated as the product of neurosphere-forming percentage and 


























3.6 Characteristics of LeX / C1qR1 and Prom1 / C1qR1 selected cells  
 
Cell surface makers LeX and Prom1 have been recognized as NSC markers and 
have been applied to enrich for NSCs cells from various sources.  To investigate whether 
greater enrichment of NSCs may be achieved by combining LeX and Prom1 expression 
with additional marker, C1qR1, cells were fractionated into different populations by flow 
cytometry using the gates illustrated in Figure 3.18.   
 
 Clonal analysis was performed by depositing cells from each purified cell fraction 
into 96-well plate at 1 cell/well.  Sorted cells were then cultured to allow neurosphere 
formation for 14 days.  For LeX and C1qR1 combination, cells from LeX+C1qR1+ 
LeX+C1qR1-, LeX-C1qR1+, and LeX-C1qR1- populations formed neurospheres at 
56.33%, 28.67%, 12.33%, and 5.67% respectively.  For Prom1 and C1qR1 combination, 
cells from Prom1+C1qR1+, Prom1+C1qR1-, Prom1-C1qR1+, and Prom1-C1qR1- 
populations formed neurospheres at 28.45%, 11.56%, 20.01%, and 7.11% respectively.   
Amongst these, the LeX+C1qR1+ subpopulation gave the highest value for NFU, 
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Figure 3.18    FACS plots of the combined assays of LeX / C1qR1 and Prom1 / C1qR1. 
 
Distribution and sorting gates (R1 – R4) of the neurosphere dissociated cells in combined assays (A) LeX / C1qR1 and (B) Prom1 / 
C1qR1.  Four regions (R2, doubly positive, R1 & R4, singly positive, R3, doubly negative) as well as the unsorted (all live cells) from 
each combined assay were sorted.  













           
 
 




     Figure 3.19    LeX+/C1qR1+ subpopulation generates highest percentage of neurospheres. 
 
     Histogram showing the percentage of neurospheres generated per single sorted cell for each subpopulation after 14 days in vitro    




















 I also performed quantitative RT-PCR analysis to test whether any difference in 
the gene expression pattern could be detected among these FACS-sorted populations.  
The expression level of markers that have been linked to NSCs was evaluated including: 
the Sox family member Sox2, the intermediate filament protein nestin, the RNA binding 
protein Musashi1, the Notch signaling pathway, Hes1 and Hes5, and the Pax family 
member Pax-6.  Analysis revealed that LeX+C1qR1+ cells had higher expression of all 
these genes (except nestin) in compared to LeX+C1qR1-, LeX-C1qR1+, LeX-C1qR1-, 
and unsorted cells.  Cells from LeX-C1qR1- population expressed all these genes at 
lower level than unsorted cells (Fig. 3.20).    
 
 In Prom1/C1qR1 combined assay, Prom1+C1qR1+ population did not show 
higher expression of NSC-specific genes compared to Prom1+C1qR1- and Prom1-
C1qR1+ populations.  However, the expression level of each gene in these three 
populations was still higher than that in unsorted population.  Similar to LeX-C1qR1- 
population, Prom1-C1qR1- cells expressed all these genes at lower level than unsorted 











Figure 3.20    Quantitative RT-PCR of NSC-specific genes for LeX/C1qR1 combined assays.  
 
Relative expression of Hes1, Hes5, Msi1, Nes, Pax6, and Sox2 in each of the FACS-sorted subpopulation was analyzed by 


























Figure 3.21    Quantitative RT-PCR of NSC-specific genes for Prom1/C1qR1 combined assays. 
  
Relative expression of Hes1, Hes5, Msi1, Nes, Pax6, and Sox2 in each of the FACS-sorted subpopulation was analyzed by 






















Unsorted Prom1+ / C1qR1+ Prom1+ / C1qR1- Prom1- / C1qR1+ Prom1- / C1qR1-
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 Given the higher number of neurospheres formed in LeX+C1qR1+ combination, 
multipotency assays were carried out to score for NSC frequency.  Individual 
neurospheres from LeX+C1qR1+, LeX+C1qR1-, and LeX-C1qR1+ populations were 
differentiated and stained for markers of the three lineages.  Upon differentiation, 81.4%, 
10.95%, and 7.65% of the LeX+C1qR1+ derived neurospheres were multipotent, 
bipotent, and unipotent respectively.  Conversely, neurospheres generated in 
LeX+C1qR1- populations were less multipotent (36.0%) and more bipotent (50.5%).  
The percentage of multipotent neurospheres generated from LeX-C1qR1+ population 
was 47.0% (Fig. 3.22).   
 
 Next, NSC frequency was calculated as the product of NFUs x % of multipotent 
neurospheres.  NSC frequency was 45.86% for LeX+C1qR1+ population, 10.32% for 
LeX+C1qR1- population, and 5.80% for LeX-C1qR1+ population.  Compared to cell 
selected with LeX alone and with C1qR1 alone, greater enrichment of embryonic NSCs 
was achieved by combining both LeX and C1qR1 selection (Fig. 3.23). 
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Figure 3.22  LeX+/C1qR1+ subpopulation generates more multipotent neurospheres. 
 
Singly-differentiated LeX+/C1qR1+, LeX+/C1qR1-, and LeX-/C1qR1+-derived 
neurospheres were scored as tripotent, bipotent or unipotent, according to the cell type 
stainings observed in each differentiated colony.  Tripotent neurospheres contain cells 
that stained positive with GFAP, ß-tubulin and O4.  Bipotent neurospheres contain cells 
that stained positive with GFAP/ß-tubulin.  Unipotent neurospheres contain cells stained 
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Figure 3.23    Greater enrichment of embryonic NSCs can be achieved by combining LeX 
expression with C1qR1. 
 
NSC frequency was estimated as the product of neurosphere-forming percentage and 































C1qR1, also known as C1qRp, Collectin receptor, and AA4 antigen in rodents, is 
a type I transmembrane glycoprotein.  It has been identified as an early marker of 
multipotent hematopoietic progenitors that can give rise to all mature blood cells [418].  
It has also been used to enrich for human HSCs [419].  However, the role of C1qR1 for 
the isolation of NSCs in murine brain has not been investigated.  In this study, using 
single-cell RT-PCR, I identified C1qR1 as a potential surface marker of NSCs.  I then 
evaluated whether C1qR1 may be a marker for the isolation of NSCs in developing 
murine brain.   
 
4.1 Search strategy for NSC markers 
 
The complexity of NSC biology and the heterogeneity of the brain and in vitro 
culture systems illustrate the need to identify more and better markers for NSCs.  Mainly 
two approaches have been used to achieve this goal: genomic and proteomic approaches.  
In genomic approach, methods have been developed for the analysis of a large number of 
genes/transcripts (reviewed in [420]).  Amongst these, DNA microarrays have been the 
predominant method used in most genomic studies in stem cell research.  DNA 
microarrays have been used by several investigators to identify genes expressed in the 
ventricular zone in vivo or in NSCs in cultures [421,422,423,424].  However, this method 
to identify specific NSC markers is labour intensive and not guaranteed to yield the 
required end product.  
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Proteomic approach has also been used to identify cell surface proteins expressed 
by NSCs.  For example, Pearce and Svendsen investigated stem cell differentiation from 
the human fetal cortex by comparing the proteins present in the cell membrane fractions 
of proliferating neurospheres to those from differentiating cells.  Even after an extremely 
short differentiation time of one hour by removal of the mitogens EGF and bFGF, they 
found differentially expressed proteins between the two groups [425].  Proteomics 
generally uses separation methods, such as 2-D gel electrophoresis or liquid 
chromatography, followed by the use of mass spectrometry to identify intact molecular 
weights or tryptic digests to obtain definitive protein identification.  
 
The feasibility of gene analysis at the single-cell level was first demonstrated by 
Li et al. in 1988 [426].  Subsequently, in the early 1990s, limited gene expression 
analyses of single cells using RT-PCR for correlating molecular and functional properties 
were been developed [427].  Multiplex single-cell RT-PCR is an ideal tool to establish a 
detailed molecular, physiological, and morphological phenotype of single cells [428].  
This approach has significantly contributed to establishing the distinctive molecular, 
functional, and morphological phenotypes of the diverse neuronal types in the cerebral 
cortex [428,429,430].  In this project, I adopted this approach to identify sets of cell 
surface markers that are unique to certain populations of neurosphere-derived cells.  I 
chose to use single-cell RT-PCR because of its exceptional sensitivity and dynamic 
range, reliability, and flexibility.  In addition, one major advantage of this approach is 
that RT-PCR is a standard procedure for many laboratories, which limits the cost, time, 
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and effort to perform the experiments.  Although this strategy does not account for 
possible differences between mRNA and protein expression, it is reasonable to assume 
that protein and gene expression patterns are generally well-correlated. 
 
Figure 2.1 outlines the general protocol for single-cell gene-expression profiling 
based on RT-PCR.  It includes several sequential experimental steps.  The procedure is 
fast and simple because one well corresponds to one cell and few manipulations are 
required.  To achieve reproducible and reliable single-cell gene expression data, each 
experimental step has been carefully optimized and validated to minimize transcript 
losses.   
 
In single-cell analysis, standard RNA extraction protocols have been replaced by 
purification-free protocols because of RNA losses.  Several lysis options are available in 
commercial market, including Single Cell-to-CTTM (Life Technologies), Real-time Ready 
Cell Lysis (Roche Diagnostics), and CelluLyser (TATAA Biocenter).  In this protocol, I 
prepared the lysis buffer using NP40, DTT, and RNase inhibitor.  Cells are lysed in this 
lysis buffer followed by freeze-thaw process.  It has been shown that this method is able 
to disrupt the cell membranes efficiently, making RNA accessible for reverse 
transcriptase.  In addition, this lysis buffer can maintain RNA integrity and is compatible 
with RT reaction. 
 
The 5μL of RT product used for the first PCR round is the optimum volume that 
does not interfere with PCR conditions (RT buffer interferes with PCR buffer) but yet 
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allows detectable amplification of the genes.  During the first PCR round, cDNAs of 
interest are amplified using multiplex primers of seven genes within one reaction.  
However, in multiplex PCR conditions, the presence of multiple primers decreases the 
amplification efficiency [428,431].  To refine the analysis, the first PCR product is re-
amplified through a second PCR using nested primers specific for one gene.  The use of 
internal (nested) primers during the second PCR rounds enhances amplification 
specificity and minimizes carry-over of primer dimers from the first PCR.  The high 
amplification efficiency and specificity of the second PCR round allows amplicons 
detection by agarose gel analysis.   
 
 The reliability of this method was assessed by the detection of the mRNAs 
encoding housekeeping genes in all single cells analyzed.  The percentage of single cells 
expressing Gapdh, Egfr, and Hprt-1 is 92.7%, 80.2%, and 91.6% respectively.  This is 
consistent in each PCR plate with p < 0.001.  However, it should be noted that the 
expression of these housekeeping genes is not 100% as expected.  One possible 
explanation is that it could be human experimental error that could have occurred during 
the various transferring steps in the whole process combined with PCR efficiency which 
is not 100% all the time.  Furthermore, the last well in each row of the PCR plate which 
has no cells in it serves as a negative control and will indicate background expression or 
presence of impurities in the reagents used if any.   
 
I used NSCs isolated from E14.5 mouse embryonic brain.  These cells can be 
maintained in culture for prolonged periods of time (several passages) without losing 
 129 
their ability to proliferate, self-renew, and differentiate.  However, when neurospheres are 
passaged for longer time periods (> 10 passages), they seem to exhibit changes their 
properties [432].  Neurospheres passaged for longer time periods become independent of 
growth factor stimulation, change their gene expression profile and show altered 
proliferative kinetics.  Therefore, I used only short-term neurosphere cultures (< 5 
passages) for this study. 
 
4.2 LeX, Prom1, and C1qR1 are useful for enriching neurosphere forming cells 
 
Having established the single cell RT-PCR approach to interrogate cells from the 
neurosphere culture system, I focused on 27 genes encoding cell surface proteins.  These 
cell surface proteins would be the most useful markers due to their accessibility in live 
cell cultures for immunostaining and for isolation of cells by FACS.  Of these only 9 
were expressed by 20% or less of the cells.  The 20% ceiling for selecting the potential 
NSC markers was set by the upper limit of the NFU obtained in our neurosphere cultures 
[433,434].  Among these surface markers, CD34, CD10, PTRF, and Oprl1 were found to 
be either not expressed or expressed at low level.  Hence, only 5 were selected for further 
investigation.  Of the 5 cell surface receptors, two, Prom1 and LeX, have already been 
used as NSC markers.  Two others, c-Kit and Eng, did not enrich for neurosphere 





4.3 C1qR1+ Cells display self-renewal and multipotent properties 
 
Currently NSCs are defined by functional properties such as self-renewal and 
multipotency.  Self-renewal is the process by which stem cells divide to make more stem 
cells, perpetuating the stem cell pool throughout life.  In the nervous system, self-renewal 
is evaluated by the ability of subcloned/passaged cells to generate secondary 
neurospheres in non-adhesion-based culture systems.  I examined the self-renewal and 
multipotency properties of C1qR1+ cells.  In secondary neurosphere formation assay, I 
observed that dissociated cells from C1qR1+-derived neurospheres generated higher 
number of secondary neurospheres compared with cells from C1qR1- derived 
neurospheres, suggesting that C1qR1+ cells present high self-renewal capacity.  
However, it has been argued that generation of a secondary or even tertiary sphere does 
not fulfill the cardinal criterion of self-renewal, as committed progenitors having limited 
regenerative potential can also form neurospheres.  Bona fide NSCs should be those that 
can be serially passaged five or six times, over an extended period of time [172].  
Therefore, to determine whether C1qR1+ cells display extensive self-renewal properties, 
I serially passaged C1qR1+ cells and found that these cells can be passaged for at least 
seven times.  This shows that C1qR1+ cells have one of the features of NSCs. 
 
 The second feature of NSCs is multipotency.  Multipotency is assessed by the 
ability of the neurosphere to differentiate into astrocytes, neurons and oligodendrocytes. 
Differentiation of bulk population of these neurospheres generated the three relevant 
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neural cell types.  Together, C1qR1+ cells exhibit NSC characteristics, suggesting that 
C1qR1 is useful surface marker for enriching NSCs. 
 
4.4 C1qR1+ cells are highly proliferative cells 
 
In addition to self-renewal and multipotency, high proliferative potential is an 
important characteristic of embryonic NSCs.  It has been revealed that putative NSCs in 
developing brains rapidly proliferate and exhibit temporally segregated symmetric self-
renewal, neurogenesis, and gliogenesis in a sequential manner [103].  In contrast, adult 
NSCs mostly stay in quiescence [88,435].  BrdU- and retrovirus-based labeling 
approaches, which require active cell division, are not effective for labeling these cells in 
vivo.  The division rates of embryonic NSCs in germinal zones may be as rapid as every 
18 hours [436], whereas adult NSCs may have a cycle time that is in the order of many 
days [88,437,438].  However, it remains unclear whether these differences are due to 
intrinsic properties and/or their local niche. 
 
I performed cell cycle analysis by flow cytometry to evaluate the proliferative 
potential of C1qR1+ cells.  Cellular DNA content was analyzed following cell staining 
with DAPI.  Instead of propidium iodide (PI), DAPI was used as DNA dye here because 
of two reasons.  Firstly, cell staining with DAPI is simpler, as it does not require 
incubation with RNase, whereas RNase needs to be added to PI staining solution because 
PI also stains double-stranded RNA.  Secondly, the C1qR1 antibody that I used is 
conjugated with R-phycoerythrin (PE) and there is a substantial spectral overlap of PI and 
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PE fluorescence emission.  This analysis revealed distribution of cells in three major 
phases of the cycle (G0/G1 vs S vs G2/M).  I found that a greater fraction (48%) of the 
C1qR1+ population was undergoing DNA synthesis and mitosis in S-G2/M phase 
compared with C1qR1- population (7%).  Therefore, C1qR1+ cells appeared to be a 
rapidly cycling population compared with C1qR1- cells.   
 
 Because colony size is also an indicator of proliferative potential and progenitor 
cells are known to exhibit limited proliferative potential capacity in relation to stem cells 
[172,439], I measured and categorized the neurospheres generated from C1qR1+ and 
C1qR1- populations into three size groups (<50 µm, 50-100 µm, and >100 µm).  I found 
that the majority of neurospheres generated from C1qR1+ cells are larger than those 
generated from C1qR1- cells.  For C1qR1+ -derived neurospheres, 85% were larger than 
50 µm and 27% were larger than 100 µm, whereas for C1qR1- -derived neurospheres, 
only 35% were larger than 50 µm and none were larger than 100 µm in diameter.  It is 
clear that C1qR1+ cells have a greater proliferative potential. 
 
Based on the premise mentioned above, a new assay called the neural colony-
forming cell assay (NCFCA)  was recently developed by Louis et al. to discriminate 
embryonic NSCs from progenitors [189].  Using NCFCA, they claimed that colonies 
greater than 2 mm are generated from NSCs while those smaller than 2 mm are from 
progenitors.  In my hands, I did not observe any neurosphere greater than 2 mm.  This is 
because the culture setting in my study is different from NCFCA.  For NCFCA, cells are 
plated at high density (100 cells/µL) and cultured for 21 days, whereas for my experiment 
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cells are plated at low density (0.67 cells/µL) and cultured for 5 days.  In fact, several 
studies utilizing NCFCA have reported that the size range of the colonies obtained was 
often not abided to [433,440,441].  Furthermore, this assay does not provide any direct 
information on self-renewal and multipotency properties of the colonies.     
 
On the whole, C1qR1+ cells appear to be a highly proliferative population 
compared with C1qR1- cells.  This further supports my findings that C1qR1 is a useful 
marker to enrich embryonic NSCs.  However, it should be noted that proliferative 
potential should not be used as principal determinants of bona fide NSCs.  The dual 
capacity of self-renewal and multipotency should be the only criteria for stemness, 
independent of mechanism or signature.  
 
4.5 C1qR1+ cells exist in neurogenic region of embryonic brain and also efficiently 
form neurospheres 
 
The properties of cultured and passaged cells, particularly cell surface markers 
used for selection, may be altered and may not be the same with the cells in vivo.  I 
therefore evaluated whether C1qR1 is also useful for identifying NSCs directly from 
primary neural tissues.  The embryonic brains at E14.5 were microdissected, dissociated 
to single cells, and FACS-sorted with C1qR1 antibody labeling.  The number of 
neurospheres derived from C1qR1+ cells was 2.1-fold higher than that of unsorted cells 
and 2.5-fold higher than that of C1qR1- cells.  Additionally, these cells possess the 
properties of self-renewal and multilineage differentiation expected of NSCs.  The 
 134 
number of secondary neurosphere colonies deriving from C1qR1+ cells was significantly 
increased compared with the negative and unsorted derived neurospheres.  These 
secondary neurospheres maintained the ability to differentiate into the three major 
lineages, suggesting that C1qR1-derived NSCs present high self-renewal and 
multipotency capacity. 
 
I also examined the expression of C1qR1 in embryonic brain cortex by 
performing immunohistochemistry.  C1qR1 is localized throughout both the VZ and SVZ 
with stronger expression in the apical VZ.  These are the areas that NSCs reside 
predominantly during development.  In the SVZ, there are a few distinct cells that 
strongly express C1qR1; these are likely to correspond to the C1qR1+ population in acute 
cell isolations.  Considering evidence that nestin+ and LeX+ NSCs exist in the SVZ, I 
compared the localization of C1qR1, nestin, and LeX.  I found that there are some 
noticeable similarities in overall distribution.  I also observed that C1qR1 colocalised 
with nestin and LeX, suggesting that it is expressed in NSCs in vivo.  Besides the SVZ 
and hippocampus, it has been reported that NSCs can be derived from non-neurogenic 
regions, such as cortical parenchyma, olfactory bulb, and spinal cord.  It will be 
worthwhile to examine the expression of C1qR1 in these regions. 
 
4.6 C1qR1 is comparable to LeX and Prom1 as a NSC marker 
 
To assess if C1qR1 is comparable to other known NSC markers, such as LeX and 
Prom1, I estimated the NSC frequency for each selection with clonal analysis.  The result 
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showed that C1qR1 is comparable to LeX and Prom1 as a NSC marker.  Given that LeX 
and Prom1 are NSC markers for both murine and human NSCs of embryonic or adult 
origin, C1qR1 expression can also be potentially used to identify and isolate NSCs from 
the asult brain.  As discussed previously, there are some limitations of the neurosphere 
assay as a read-out for NSC frequency [172,174].  One of the limitations of the 
neurosphere assay is the significant degree of neurosphere fusions in suspension cultures, 
which questions the accuracy of the common practice of using neurosphere numbers as 
an indicator of stem cells [164].  Therefore, to ensure the clonality of neurospheres, 
single cells from each population were plated directly into a 96-well plate with a FACS-
automated cell deposition unit.  After 2 weeks, individual neurospheres derived from 
each population were differentiated to examine the multipotency. 
  
 It is noted that not all C1qR1+ cells behave like NSCs.  Clonal neurosphere 
formation assay showed that only 43% of C1qR1+ cells generated neurospheres.  
C1qR1+ cells that do not generate neurospheres may be non-NSCs; for example, the 
immediate progeny of NSCs that still retain C1qR1 expression.  Or perhaps they are 
NSCs but cannot survive due to two possible reasons: 1) the unfavorable environmental 
conditions, such as clonal cell density, or 2) the occurrence of cell damage resulting from 
FACS sorting.  
 
Clonal analysis has been viewed as one of the critical mainstays to identify NSC.  
However, to succeed in clonal analysis, a single NSC needs to survive and retain the 
ability to divide and respond to growth factors [187].  Cell density has been identified as 
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one of the factors that influences the survival and proliferation of NSCs.  It has been 
demonstrated that NSC proliferation is increased when cells are grown at high density in 
EGF and bFGF [184].  This led to a speculation that an unknown factor is produced by 
cells plated at high density.  In addition, high-density plating may help to increase the 
stem cell sensitivity to growth factors via cell-cell interaction and crosstalk between cell 
surface receptors [442].   Therefore, under clonal conditions, a NSC may fail to develop a 
new sphere due to lack of survival or loss of proliferation potential.  And consequently, 
this will affect the estimation of NSC frequency. 
 
Cell damage that occurs during FACS sorting might be another reason that 
C1qR1+ cells do not generate neurospheres.  FACS sorter is a flow cytometry analyzer 
with the added ability to sort cells based on their light scatter properties, 
immunofluorescent labels, and dye binding characteristics.  A suspension of cells is 
pumped single file through a nozzle and interrogated with one or more lasers.  The nozzle 
vibrates at high frequency, creating droplet formation downstream from the stream-laser 
intercept.  Droplets containing cells of interest are then electrostatically charged, 
deflected, and collected in individual containers, including tissue culture plates.  Using 
this instrument, cell can be sorted with a great degree of purity.  However, a major 
problem that has developed involves the fact that the cell viability decreases after sorting.  
It is hypothesized that this damage is mainly due to the hydrodynamic stress that the 
sorter imposes upon cells, during the cell sorting process.  Seidl et al. examined necrosis 
and apoptosis in normal human skin fibroblast cell line N1 and human breast carcinoma 
cells BT474 after FACS sorting [443].  They found that FACS resulted in relatively high 
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levels of necrosis in both cell lines, approximately 10 to 15% above the controls, based 
on the flow cytometric propidium iodide dye exclusion assay.  With Annexin-V/PI 
apoptosis assay, they also discovered that FACS induced apoptosis occurred in high 
percentages of BT474 cells, but not the skin fibroblast cells. 
 
I estimated NSC frequency as the product of primary neurosphere formation 
percentage and multipotent neurosphere percentage.  Based on this equation, the NSC 
frequency obtained by C1qR1 selection (29%) is similar to that obtained by LeX 
selection (25%) and Prom1 selection (21%), suggesting that C1qR1 is comparable with 
LeX and Prom1 as a NSC marker.  Reynolds and Rietze emphasized the importance of 
multiple passaging as an indicator of self-renewal, since progenitor cells can also 
generate secondary and even tertiary neurospheres [172].  This was not performed here 
because the neurospheres were generated at clonal density (one cell per well).  Moreover, 
neural progenitors were excluded in the calculation of NSC frequency by taking only the 
percentage of multipotent neurospheres.  Only NSCs generate multipotent neurospheres.  
Progenitor cells generate at best bipotent neurospheres. 
 
Differentiating single neurospheres has its technical challenges.  We observed in 
our lab that differentiating neurospheres individually gives rise to almost exclusively 
astrocytes, if they even survive at all.  We speculated that single neurosphere 
differentiation requires conditioned medium from differentiating bulk culture cells which 
contains secreted factors that support the survival and proper differentiation of 
neurospheres.  Therefore, we developed a differentiation set-up where single 
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neurospheres adhered on a floating coverslip were co-cultured with a lawn of dissociated 
differentiating cells at the bottom of culture dish.  Individual neurospheres were plated on 
a single well of a 50-well coverslip and dissociated NSCs were differentiated in a 10 cm 
dish in parallel.  The following day, the 50-well coverslip containing the attached single 
neurospheres was then inverted onto the 10 cm differentiating dish.  Special care was 
taken to ensure that neurospheres on the coverslip did not come into contact with the 
differentiating cells beneath.  In this way, differentiating cells conditions the medium 
with neurotrophic factors that helps to support survival and differentiation of the single 
neurospheres on the coverslip.  We found that this method of differentiating single 
neurospheres efficiently gave rise to neurospheres containing astrocytes, neurons and 
oligodendrocytes. 
 
4.7 Combination of C1qR1 and LeX further enriches for NSCs 
 
Next I determined whether double selection might improve the enrichment of 
NSCs by C1qR1.  Cells were sorted for C1qR1 with either LeX or Prominin and 
compared for clonal neurosphere formation and gene expression.  In neurosphere assay, I 
observed that double-selection C1qR1+LeX+ and C1qR1+Prom1+ selected for 
neurosphere-forming cells more efficiently than each individual selection.  Additionally, 
the C1qR1+LeX+ population formed neurospheres two times more efficiently than the 
C1qR1+Prom1+ population.   
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To evaluate whether there are any differences between each subpopulation of 
combinatorial analysis at the genetic level, a panel of known NSC markers was analyzed.  
Gene profiling of each subpopulation revealed that all the FACS-sorted double positive 
cells and single positive cells expressed significantly higher levels of Hes1, Hes5, 
Musashi1, nestin, Pax6, and Sox2 as compared with unsorted cells and double negative 
cells.  However, there is no significant difference in the expression levels of all these 
genes (except Pax6) between each double positive and single positive subpopulation.  A 
possible explanation of this observation is that although these genes have been reported 
as NSC associated genes, they are also expressed in neural progenitors and hence the 
bona fide NSCs cannot be distinguished from the progenitors by the gene expression 
level.  
 
I then performed multipotency assay to estimate the NSC frequency.  Upon 
differentiation, more than 80% of the LeX+C1qR1+ derived neurospheres were found to 
be tripotent.  The result revealed that C1qR1+LeX+ selection gave greater enrichment of 
NSCs compared to individual selection.  In fact, several studies have reported a similar 
strategy in NSC enrichment.  Nagato et al. reported that syndecan-1 in combination with 
Notch-1 selected for neurosphere-forming cells more efficiently than each individual 
selection [272].  Kim and Morshead also reported that when side-population analysis was 
combined with LeX expression, a slight enrichment was seen over side-population 
analysis alone [248].  Similarly, Barraud et al. also suggested that SSEA4 associated with 
Prom1 can be used for the enrichment of NSCs from human embryonic forebrain [302].  
Amongst these, combination of C1qR1 and LeX gave the highest NSC frequency (46%).   
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On the other hand, negative selection strategies have also been developed as an 
alternative method to enrich for both human and mouse NSCs.  For example, Uchida et 
al. enriched for human embryonic NSCs by using Prom1 combined with negative 
selection of CD34 and CD45 [198].  Also, the frequency of mouse neurosphere forming 
cell is higher with Prom1+CD24- selection compared to Prom1+ alone selection [268].   
 
Taken together, it is clear that using markers in combination could be a useful 
strategy to further purify the stem cell population.  This is because most of the reported 
markers are not specific to NSCs.  They are also shared by other stem cells.  Moreover, 
these markers may be expressed in low amounts at several stages in the lineage or in 
differentiated cells as well.  Using a combination of markers will rule out the ‘false 
positives’.   
 
4.8 100% NSC frequency 
 
How to obtain 100% NSC frequency?  This is one of major challenges in NSC 
biology study.  Thus far, several FACS strategies have been applied to sort NSCs from 
CNS using different combinations of surface markers (positive and/or negative selection), 
side population analysis, or cell size (>12 µm diameter) as selection criteria.  Although 
these FACS strategies have led to varying degrees of success with variable level of NSC 
enrichment, none have provided a pure population of NSCs.  To date, all the reported 
NSC markers to date are either shared with other stem cells or shown to be present in the 
progenitor cells as well.  Therefore, the discovery of specific and unique markers of 
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NSCs could be the key step in achieving 100% NSC frequency.  Nevertheless, the quest 
for definitive markers is challenging due to substantial overlap among the factors 
involved in proliferation and survival and those that regulate lineage commitment and 
cellular differentiation.  For example, apart from the effect on survival and proliferation, 
bFGF influence lineage commitment by embryonic NSCs.  Withdrawal of bFGF from 
NSCs culture promotes generation of neurons and glia, suggesting that the factor 
represses intrinsic programs of NSCs differentiation.  In addition, the concentration of 
bFGF to which embryonic stem cells are exposed in vitro influences cell fate; low 
concentration of bFGF favor neuronal differentiation, whereas higher threshold 
concentrations favor oligodendroglial differentiation [444].  
 
As discussed previously, NSCs are identified retrospectively by functional assays 
through the formation of a neurosphere.  It should be noted that these assays demand 
survival and proliferation of the NSCs so that a clonal colony can be seen.  An inability to 
observe a neurosphere in vitro could be an indication that 1) NSCs are not present, 2) 
NSCs are present but do not proliferate, or 3) the initial progeny of the NSCs are dying.  
Therefore, in the continued quest for a unique marker for NSCs, technical issues that 
affect NSC survival in clonal assays need to be addressed as well.  Firstly, the culture 
condition of NSCs.  An optimal culture condition for NSCs is required to reduce the 
extensive cell death that occurs when the cells are plated in serum-free conditions.  
Chang et al. showed that the survival rate of embryonic NSCs were markedly increased 
by supplementing conditioned medium prepared from their dense cultures [445].  
Similarly, Shen et al. demonstrated that when co-culture with NSC, endothelial cells 
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release soluble factors that can stimulate and enhance neurosphere formation [446].  
These studies suggest that there are factors other than those provided in the culture 
medium cocktail that can maximize NSC survival and proliferation.   
 
Secondly, cell sorting techniques.  FACS is a powerful tool for isolating certain 
cell population defined by their antigen presentation.  However, the exposure to 
hydrodynamic forces during sort processes resulted in loss of cell membrane integrity, 
which led to a significant reduction of cell viability.  Conversely, magnetic-activated cell 
separation (MACS), another established sorting technique, was showed to have negligible 
effect on cell viability as compared to FACS.  However, a clear hyperpolarization and 
altered phospholipid distribution of cell membrane due to the exposure to high gradient 
magnetic fields were observed [443].  Seild et al. concluded that neither technique is 
physiologically preferable for subsequent analysis or recultivation of the sorted cells 
[443].  Therefore, there is still a need to optimize the sort conditions in both cell 
separation techniques.  Alternatively, improved cell separation instruments/techniques for 
the purification of NSCs should be developed in future.  Taken together, without an 
optimal cell sorting and culture condition, the in vitro functional assays of NSCs will be 
inherently compromised due to the initial loss of the very cells that are intended for study. 
 
4.9 C1qR1, HSCs and NSCs 
 
Recent reports suggest that HSCs and NSCs share some common characteristics.  
That is, HSCs and NSCs express some common antigens and/or genes, [198,423,447] or 
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have the potential to transdifferentiate into each other in vivo [77].  Prom1, Integrins, and 
Syndecan-1, markers of HSCs, have also been reported to be useful in isolating NSCs 
[198].  Here, I reported another HSC marker, C1qR1, is expressed by NSCs and 
represents a convenient marker for the prospective isolation of NSCs. 
 
C1qR1 is a 126-kDa type 1 transmembrane glycoprotein.  This molecule displays 
strong homology (67 – 87% identity) across humans, mice, and rats [448,449].  C1qR1 
was originally identified as a B cell lineage marker in 1985 [450].  During mouse 
embryonic development, C1qR1 is expressed in three major cell types: vascular 
endothelial cells, aorta-associated hematopoietic clusters, and primitive fetal liver 
hematopoietic stem cells (HSCs).  In the adult, C1qR1 is detected in lung, heart, and 
whole bone marrow [451].  Recent studies demonstrated that expression of the C1qR1 
antigen parallels early stages of hematopoietic development during the in vitro 
differentiation of embryonic stem cells (ESCs) [452,453].  Moreover, transfer of a 
C1qR1+CD45R- subpopulation of differentiating ESCs into lymphoid-deficient mice 
resulted in the long-term repopulation of both T and B lymphoid compartments with a 
complete restoration of immune functions [454].  Together, these studies revealed that 
C1qR1 defines a population of multipotential HSCs that can differentiate into the entire 
spectrum of mature cells of the blood system.       
 
The exact molecular function of C1qR1 is yet to be identified.  It has been 
suggested that C1qR1 is a cellular receptor for C1q that plays a role in C1q-mediated 
phagocytosis by monocytes [455].  It has also been suggested that C1qR1 may function 
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as an intercellular adhesion molecule [456].  However, a study using C1qR1-deficient 
mice revealed that C1qR1 interacts with C1q only under nonphysiological conditions.  It 
does not appear to play a key role in C1q-mediated enhancement of phagocytosis or in 
intercellular adhesion.  Instead, it was suggested that C1qR1 may contribute to the in vivo 
clearance of dying cells [457].  
   
 It has been found that C1q is synthesized in the brain in response to multiple 
kinds of injuries and neurodegenerative diseases, such as stroke [458], experimental brain 
lesioning [459], Huntington’s disease [460], and Alzheimer’s disease [461,462].  More 
recently, it was demonstrated that C1qR1 mRNA and protein are up-regulated in 
ischemic mouse brain.  It was further shown that C1qR1 can protect the brain after 
cerebral ischemia via suppression of neuroinflammatory response through 
downregulation of CCL21 [463].  In addition, expression of C1qR1 is also detected in a 
subset of pyramidal neurons in the normal human brain [464].  Collectively, these studies 
led to the speculation that C1qR1-expressing cells may represent a stem cells population 
in the brain. 
 
Using powerful custom microarrays to study gene expression patterns of CNS 
progenitors, Geschwind et al. discovered novel genes specifically expressed in the 
germinal areas of the embryonic and adult mouse brain [421].  Building on this work, 
Terskikh et al. showed that some of these genes are also enriched in HSCs, suggesting 
that NSCs and HSCs share similar genetic programs and signaling strategies [423]. 
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In 1999, Bjomson et al. demonstrated that NSCs could also differentiate into a 
variety of hematopoietic cells, including the myeloid and the lymphoid cell lineages, as 
well as more immature blood cells [77].  A year later, marrow-derived cells were reported 
to express neuronal markers in tissue culture [465].  Subsequently, two groups of 
researchers, Brazelton et al. and Mezey et al. demonstrated that transplanted bone 
marrow-derived cells can gain access to the brain and differentiate into cells that express 
neuron-specific genes [75,76]. 
 
Taken together, these studies revealed that stem cells from different tissue may 
retain a general self-renewing and differentiation capacity or pluripotency [466].  These 
core features of stem cells are accompanied by the expression of a core set of genes.  
Hence, based on this concept, it is not surprising that several markers are shared by HSCs 
and NSCs.  However, it remains to be determined whether the shared markers truly serve 
unique stem cell functions or are shared for other reasons.     
 
In conclusion, C1qR1 appears to be a useful marker for the isolation of mouse 
embryonic NSCs.  Clonal analysis of the cells showed that C1qR1 expressing cells 
display higher self-renewal and multipotency capacity compared to unsorted cells.  I 
demonstrated that C1qR1-positive cells isolated from embryonic brain can generate 
neurospheres and differentiate into the three major neural lineages.  Many of the C1qR1-
expressing cells also express nestin and LeX, markers of NSCs.  Further enrichment for 
NSCs was obtained when C1qR1 expression was combined with LeX expression, 
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